














































































































































































Acknowledgements# # # # # # # # # ####ii#
Preface!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! ! ! ! ! ! !! ####iv#
List!of!Figures! ! ! ! ! ! ! ! ! ! ####xi#
List!of!Tables! ! ! ! ! ! ! ! ! ! ####xv#
List!of!Abbreviations! ! ! ! ! ! ! ! ! ####xvi#
Abstract! ! ! ! ! ! ! ! ! ! ####xix#
Chapters!
1. Small!Heat!Shock!Proteins!as!“Undruggable”!Targets! ! ! ! ####1!
1.1.#Abstract# # # # # # # # # ####1#
1.2.#Challenges#associated#with#nonQenzyme#targets## # # # ####1#
1.3.#Small#heat#shock#proteins#are#examples#of#nonQcanonical#targets# # ####3#
1.4.#sHsps#are#genetically#validated#therapeutic#targets#in#neurodegenerative#diseases##7#
1.4.1.#Amyotrophic#lateral#sclerosis# # # # # # ####7#
1.4.2.#Alexander’s#disease# # # # # # # ####8#
1.4.3.#Alzheimer’s#disease# # # # # # # ####8#
1.4.4.#Parkinson’s#disease# # # # # # ##################10#
1.4.5.#Prion#diseases# # # # # # # # ####11#
1.5.#sHsps#are#potential#therapeutic#targets#in#ischemic#stroke## # # ####11#
1.6.#sHsps#are#potential#therapeutic#targets#in#cancers# # # # ####12#
1.7.#sHsps#are#nonQcanonical#drug#targets# # # # # # ####13#
1.8.#Strategies#for#ligand#discovery#for#noncanonical#drug#targets# # # ####14#
# 1.8.1.#AffinityQbased#techniques#for#ligand#discovery# # # # ####14#
# 1.8.2.##StabilityQbased#methods#for#ligand#discovery# # # # ####18#




# proteins## # # # # # # # # #####26#
1.11.#Notes## # # # # # # # # #####27#
1.12.#References# # # # # # # # # #####27#
#
2. Mutations!in!sHSPs!Destabilize!the!Native!Fold!and!Favor!Formation!of!Amyloids! !!!!!39!
2.1.#Abstract# # # # # # # # # #####39#
2.2.#Introduction# # # # # # # # # #####39# #
2.3.#Mutants#in#sHsps#are#associated#with#disease# # # # # #####40#
2.4.#Hot#spot#mutation#destabilizes#the#dimeric#substructure#of#αBQcrystallin#and##
leads#to#its#aggregation# # # # # # # # #####40#
2.5.#Amyloids#are#ordered#protein#aggregates#that#overwhelm#the#proteostasis##
network# # # # # # # # # # #####41#
2.6.#Pathological#point#mutations#are#clustered#in#the#dimer#interface## # #####41#
2.7.#Small#heat#shock#proteins#are#predicted#to#form#amyloids# # # #####44#
2.8.#Aggregates#formed#from#αBQcrystallin#are#amyloids#and#this#conversion#is##




aggregation## # # # # # # # ## #####53#
2.12.#The#S135F#mutation#destabilizes#the#core#domain#dimer#and#results#in#
aggregation## # # # # # # # # #####54#
2.13.#Conclusions#and#future#work# # # # # # # #####56#
# 2.13.1.#Model#for#sHsp#aggregation#and#amyloid#formation# # # #####56#
# 2.13.2.#Additional#evidence#that#mutant#sHsps#cause#gainQofQfunction#aggregation##
# # diseases# # # # # # # # #####57#
# 2.13.3.#The#potential#use#of#pharmacological#chaperones#to#recover#mutant##
# # pathologies# # # # # # # # #####58#
2.14.#Experimental#procedures# # # # # # # #####58#
# 2.14.1.#QuikChange#mutagenesis# # # # # # #####58#
# 2.14.2.#Purification#of#Hsp27c#or#αBQcrystallin#core#domain# # # #####58#
# 2.14.3.#Purification#of#full#length#Hsp27#and#R140G#Hsp27# # # #####60#
## viii#
# 2.14.4.#Purification#of#HisQtagged#αBQcrystallin#and#R120G#αBQcrystallin# # #####60#
# 2.14.5.#Electron#microscopy# # # # # # ###################61#
# 2.14.6.#Light#scattering#assay#of#protein#aggregation# # # # #####61#
# 2.14.7.#Thermal#stability#measurements## # # # #### #####61#
# 2.14.8.#HSQC#NMR# # # # # # # # #####61#
2.15.#Notes## # # # # # # # # #####62#
2.16.#References# # # # # # # # # #####62#
# # # # #
3. Pharmacological!rescue!of!an!aggregationOprone!small!heat!shock!protein!!
!!!!!!!in!a!cataract!model!! ! ! !! ! ! ! ! !!!!!66!
3.1.#Abstract# # # # # # # # # #####66#
3.2.#Introduction# # # # # # # # # #####66#
3.3.#Pharmacological#chaperones#for#canonically#‘undruggable’#proteins# # #####67#
3.4.#Differential#scanning#fluorimetry#as#a#discovery#tool#for#pharmacological##
# chaperones# # # # # # # # # #####67#
3.5.#Compound#29#can#prevent#and#reverse#amyloid#formation#in%vitro# # #####72#
3.6.#Compound#29#can#reverse#aggregation#in%vivo#in#R120G#knockQin#mice#and##
% ex%vivo#in#human#cataract#tissue## # # # # # #####73#
3.7.#Conclusions#and#outlook# # # # # # # #####75#
3.8.#Experimental#procedures# # # # # # # #####76#
# 3.8.1.#Protein#purification# # # # # # # #####76#
# 3.8.2.#High#throughput#DSF#screen# # # # # # #####77#
# 3.8.3.#HTS#data#analysis### # # # # # # #####77#
# 3.8.4.#Light#scattering#assay#of#protein#aggregation# # # # #####78#
# 3.8.5.#Electron#microscopy# # # # # # # #####78#
# 3.8.6.#Binding#to#αBQcrystallin#by#biolayer#interferometry#(BLI)# # # #####78#
# 3.8.7.#NMR# # # # # # # # # #####79#
# 3.8.8.#Docking# # # # # # # # # #####80#
# 3.8.9.#Animals#and#lenses# # # # # # # #####80#
# 3.8.10.#Treatment#of#mice# # # # # # # #####80#
# 3.8.11.#Slit#lamp#biomicroscopy### # # # # # #####80#
# 3.8.12.#Measurement#of#waterQsoluble#lens#crystallins# # # # #####81#
## ix#
# 3.8.13.#Treatment#and#analysis#of#human#lenses## # # # #####81#
3.9.#Notes# # # # # # # # # # #####82#
3.10.#References# # # # # # # # # #####82#
# # # #
4. Chemical!Validation!of!Cryptic!Binding!Sites!on!Hsp27!using!In#Silico!Solvent!!
!!!!!!!!Mapping!and!Biophysical!Methods!! ! ! ! ! ! !!!!!85!
4.1.#Abstract# # # # # # # # # #####85#
4.2.#Structural#aspects#of#small#heat#shock#proteins# # # # # #####86#
4.3.#Atomic#level#structure#of#core#αQcrystallin#domain#of#Hsp27# # # #####86#
4.4.#Identification#of#binding#sites#within#Hsp27’s#αQcrystallin#domain# # #####87#
4.5.#Validation#of#MixMD#result#through#equivalent#NMR#experiments#and##
# comparison#with#chemical#shift#perturbations# # # # # #####89#
4.6.#Validation#of#cysteineQcontaining#Site#1# # # # # # #####89#
4.7.#Site#2#is#involved#in#proteinQprotein#interactions## # # # #####93#
# 4.7.1.#Effect#of#peptide#binding#on#quaternary#structure#of#Hsp27## # #####94#
# 4.7.2.#Effect#of#peptide#binding#on#stability#of#an#sHsp# # # # #####95#
4.8.#Validation#of#dimerQinterface#Site#3#through#fragmentQbased#drug#design# #####97#
# 4.8.1.#Resynthesis#of#screening#hits#and#confirmation#of#binding#to#Site#3## #####98#
# 4.8.2.#Confirmation#of#fragment#binding#site#with#mutagenesis## # #### ###101#
4.9.#Conclusions# # # # # # # # # ###103#
4.10.#Experimental#procedures# # # # # # ### ###103#
# 4.10.1.#Protein#purification# # # # # # # ###103#
# 4.10.2.#NMR#studies# # # # # # # # ###104#
# 4.10.3.#SECQMALS# # # # # # # # ###104#
# 4.10.4.#Light#scattering#assay# # # # # # # ###104#
4.11.#Synthetic#procedures#and#analytical#characterization# # # # ###104#
# 4.11.1.#Peptides#from#BAG3#sequence# # # # # # ###105#
# 4.11.2.#Synthesis#of#fragment#screening#hits#1Q4# # # # # ###105#
# 4.11.3.#Synthesis#of#analogues#of#fragment#screening#hit#4# # # ###108#
4.12.#Notes## # # # # # # # # ###115#
4.13.#References# # # # # # # # # ###116#
5. Conclusions!and!Future!Directions! ! ! ! ! ! ! !!!119!
## x#
5.1.#Conclusions# # # # # # # # # ###119#
5.2.#Future#directions# # # # # # # # ###121#
# 5.2.1.#Immediate#next#steps#in#ligand#development#for#sHsps# # # ###121#
# 5.2.2.#The#use#of#chemical#probes#to#address#outstanding#questions#in##
# # sHsp#biology# # # # # # # # ###122#
# 5.2.3.#Development#of#firstQinQclass#ligands#for#nontraditional#or#‘undruggable’##
# # targets# # # # # # # # # ###123#
#######5.3.#Closing#thoughts:#the#concept#of#‘druggability’#is#evolving# # # ###125#
#######5.4.#References# # # # # # # # # ###126#
Appendix:!Evaluation!of!a!differential!scanning!fluorimetry!platform!to!!
!!!!!!identify!ligands!of!the!transcription!factor!HSF1! ! ! ! !!!!! !!!127! #
#####A.1.#Abstract## # # # # # # # # ###127#
#####A.2.#HSF1#is#the#master#regulator#of#the#heat#shock#response# # # #### ###127#
# A.2.1.#Activation#of#HSF1# # # # # # # ###127#
# A.2.2.#Domain#structure#of#HSF1# # # # # # ###128#
# A.2.3.#HSF1#is#a#nonQcanonical#therapeutic#target# # # # ###129#
#####A.3.#Characterization#of#HSF1#by#differential#scanning#fluorimetry# # ##### ###130#
#####A.4.#Optimization#of#screening#conditions# # # # # # ###131#
A.5.#Pilot#high#throughput#screen#for#small#molecule#ligands#of#HSF1# # # ###137#
A.6.#Alternative#screening#strategies# # # # # # # ###140#
A.7.#Preliminary#electron#microscopy#and#DNA#scaffolding#strategy#to#visualize#complex######143#
A.8.#Conclusions#and#future#directions# # # # # # # ###145#
A.9.#Experimental#procedures# # # # # # # # ###145#
# A.9.1.#Differential#scanning#fluorimetry#optimization# # # # ###145#
# A.9.2.#Differential#scanning#fluorimetry#pilot#screen# # # # ###146#
# A.9.3.#Electrophoretic#mobility#shift#assay# # # # # ###146#
# A.9.4.#Electron#microscopy# # # # # # # ###146# #
A.10.#Notes# # # # # # # # # # ###147#










1.1.#NonQenzyme#targets#present#unique#challenges#to#drug#discovery.# # # #########3# #
1.2.#Alignment#of#primary#sequences#of#six#human#small#heat#shock#proteins.# # #########5#
1.3.#Atomic#resolution#structures#of#core#domain#dimers#of#αBQcrystallin,#Hsp27,#and#Hsp22.####5#
1.4.#Model#for#sHsp#client#protection.# # # # # # # #########6#




########amyloids#by#ZipperDB#analysis.# # # # # # # #######45#
2.3.#R120G#αBQcrystallin#aggregates#rapidly#under#mild#conditions#and#at#relatively#low#######
########concentrations.# # # # # # # # # #######46 
2.4.#Dense#aggregates#are#observed#within#30#minutes#of#incubation#at#room##
########temperature#for R120G#αBQcrystallin.# # # # # # #######46 
2.5.#Thermal#stability#measurements#of#αBQcrystallin,#Hsp27,#and#mutants.# # #######47# #
2.6.#Mutant#aBQcrystallin#is#prone#to#forming#amyloids#during#the#DSF#experiment.# #######48 
2.7.#Aggregation#of#R140G#and#wild#type#Hsp27#as#measured#by#light#scattering##
#########and#electron#microscopy.## # # # ## # # # #######49#
2.8.#Hsp27#forms#amyloids#accelerated#by#the#pathological#mutation#R140G#by##
########electron#microscopy# # # # # # # # #######50#




##########at#46#°C.# # # # # # # # # # #######54#
2.13.#1H,15N#QHSQC#spectrum#of#wild#type#Hsp27#and#S135F#mutant#Hsp27#core##
##########domains.# # # # # # # # # # #######55#
2.14.#The#S135F#Hsp27#core#domain#aggregates#more#quickly#than#the#wild#type##
## xii#
#########protein#and#slightly#faster#than#R140G#mutant.# # # # # ######56#
2.15.#Purified#core#domains#and#fullQlength#constructs.# # # # # ######60#




########wild#type#protein#remains#soluble#and#transparent.# # # # # ######69 
3.4.#Summary#of#DSF#screen#against#Hsp27.## # # # # # ######70#
3.5.#Structures#of#compounds#28,#29,#and#negative#control#16#and#associated#percent##
########recoveries#in#Tm.# # # # # # # # # ######70#
3.6.#Compounds#28#and#29,#but#not#the#control#compound#16,#bound#to#the#protein##
########and#recovered#the#Tm#of#R120G#αBQcrystallin.# # # # # ######71 
3.7.#Binding#of#compound#29#to#immobilized#R120G#αBQcrystallin#by#BLI.### # ######71#




##########and#in#aged#wild#type#mice.# # # # # # # ######74#
3.12.#Treatment#with#compound#29#improves#the#solubility#of#α,#β,#and#γQcrystallins#in#
##########mouse#lenses#as#measured#by#gel#permeation#chromatography.# # # ######75#
3.13.#Model#for#the#action#of#compound#29#as#a#pharmacological#chaperone.## # ######75 
4.1.#Solution#NMR#structure#of#Hsp27#αBQcrystallin#domain#and#features#of#the#primary######
########sequence#of#Hsp27#ACD.# # # # # # # # ######87# #
4.2.#Surface#rendering#of#NMR#structure#of#Hsp27#αBQcrystallin#domain#showing#regions##
########where#each#MixMD#solvent#probe#was#highly#localized.# # # # ######88#
4.3.#MixMD#solvent#probe#occupancy#maps#and#backbone#chemical#shift#perturbations##
########for#solvent#mapping#NMR#experiment.## # # # # # ######89#
4.4.#Captopril#decreases#the#apparent#melting#temperature#of#fullQlength#Hsp27#as##
########measured#by#differential#scanning#fluorimetry.# # # # # ######90#
4.5.#HSQC#NMR#chemical#shift#perturbations#indicate#that#captopril#interacts#with##
########C59A#Hsp27c.## # # # # # # # # ######91#




########and#untreated#Hsp27.## # # # # # # # ######95#
4.8.#Peptides#from#BAG3#suppress#the#aggregation#of#R140G#Hsp27#as#measured##
########by#light#scattering.### # # # # # # # ######96#
4.9.#Peptides#from#BAG3#suppress#the#aggregation#of#R120G#αBQcrystallin#as##




#########the#NMR#fragmentQbased#screen.# # # # # # #### ######98#
4.12.#Identification#of#correct#structure#of#compound#3#from#3JHH#coupling#analysis.# ######99#
4.13.#Backbone#chemical#shift#perturbations#from#compound#11#binding#to#Hsp27c#do#not#####
##########permit#differentiation#between#Site#1#and#Site#3.# # # # # ####102#
4.14.#Summary#of#mutagenesis#studies#for#binding#of#11#to#Hsp27#with#residues#in#Site#1##
##########or#Site#3#mutated.## # # # # # # # ####103# #
5.1.#Biophysical#methods#for#ligand#discovery#for#the#‘undruggable’#sHsps#resulted#in#four##
########scaffolds#with#affinity#for#three#distinct#sites#in#the#conserved#core#αQcrystallin##
########domains#of#αBQcrystallin#and#Hsp27.# # # # # # ####120#
5.2.#General#workflow#for#the#identification#of#ligands#for#nonQcanonical#targets.## ####124#
A.1.#HSF1#trimerizes,#translocates#to#the#nucleus,#and#initiates#expression#of#heat#shock##
########proteins#in#response#to#stress#conditions.# # # # # # ####128#
A.2.#Domain#architecture#of#HSF1#and#idealized#heat#shock#element#sequence.# # ####129#
A.3.#Binding#of#HSE#but#not#the#HSE#mutant#induces#a#large#and#dose#dependent#increase##
########in#the#apparent#thermal#stability#of#HSF1.# # # # # # ####131#
A.4.#DMSO#concentration#does#not#affect#the#change#in#Tm#from#HSE#binding.# # ####132#
A.5.#Optimization#of#NaCl#concentration#for#detection#of#HSF1QHSE#complex#formation##
#########by#differential#scanning#fluorimetry.# # # # # # ####133#
A.6.#Effect#of#the#reducing#agent#DTT#on#HSF1QHSE#complex#monitoring#by#differential##
#########scanning#fluorimetry.# # # # # # # # ####134#
A.7.#Effect#of#reducing#agent#TCEP#on#HSF1QHSE#complex#monitoring#by#differential##
#########scanning#fluorimetry.# # ### # # # # # ####135#
## xiv#
A.8.#Effect#of#varying#TCEP#concentration#on#HSF1QHSE#complex#detection#by#differential######
########scanning#fluorimetry.# # # # # # # # ###135#
A.9.#Effect#of#varying#MgCl2#concentration#on#HSF1QHSE#complex#detection#by#differential##
#########scanning#fluorimetry.## # # # # # # # ###136#
A.10.#Inclusion#of#detergent#TweenQ20#does#not#appear#to#affect#Tm#observed#for##
##########HSE#binding.# # # # # # # # # ###136#
A.11.#The#presence#of#nucleotide#affects#Tm#of#free#and#bound#HSF1#and#the#ΔTm#of##
##########HSE#binding#but#the#reason#for#this#effect#is#unknown.# # # # ###137#
A.12.#Flowchart#of#highQthroughput#screening#process.# # # # # ###138#
A.13.#Result#of#singleQconcentration#reconfirmation#(at#10#μM)#from#16#repurchased#or####
###########borrowed#hits.## # # # # # # # # ###139#
A.14.#Chemical#structures#of#16#hits#assembled#for#retesting.# # # # ###140#
A.15.#No#hit#compounds#reconfirmed#of#the#16#that#were#reQtested#in#the#primary#
##########screening#assay.# # # # # # # # # ###140#
A.16.#An#alternative#setup#for#a#DSFQbased#HTS#may#rely#on#DNA#binding#as#a#reporter##
##########of#quaternary#structure.# # # # # # # # ###141#
A.17.#Alternative#constructs#of#HSF1#that#may#prove#useful#in#HTS#efforts.# # ###142#
A.18.#DSF#characterization#of#alternative#constructs#of#HSF1#that#may#prove#useful#in##
##########conducting#or#interpreting#future#HTS#efforts.# # # # # ###143#
A.19.#Preliminary#negative#stain#electron#microscopy#images#of#HSF1#in#the#absence##
##########of#DNA.# # # # # # # # # # ###144#
A.20.#Organization#of#five#tandem#repeats#of#heat#shock#elements#in#oligonucleotide,##









































































































































































































With" the" emergence" of" genomic" and" proteomic" information," the" preferred" methods" for"
identification"of"new"drug"targets"have"changed"dramatically."Modern"tactics"such"as"genome;
wide" association" studies" (GWAS)" and" deep" sequencing" are" fundamentally" different" from" the"
pharmacology;guided" approaches" used" previously," in" which" knowledge" of" small" molecule"
ligands"acting"at"their"cellular"targets"was"the"primary"discovery"engine."A"consequence"of"the"
“target;first," pharmacology;second”" strategy" is" that" many" predicted" drug" targets" are" non;
enzymes," such" as" scaffolding," regulatory" or" structural" proteins," and" their" activities" are" often"





often" later" earn" the" designation" of" “undruggable.”" Can" the" scope" of" available" targets" be"
widened" to" include" these" promising," but" challenging," non;enzymes?" In" this" chapter," we"
introduce" a" class" of" molecular" chaperones" called" small" heat" shock" proteins" as" examples" of"
genetically" identified" therapeutic" targets," with" a" focus" on" the" aspects" of" small" heat" shock"







The"majority" of" current" drug" targets" are" G;protein" coupled" receptors," nuclear" receptors," ion"
channels"or"enzymes" (e.g." kinases,"proteases,"deacetylases,"etc.)" (1,"2)."Many"of" these" targets"
were"historically" identified"based"on"their"pharmacology:"agonists"or"antagonists"were"used"to"
probe" the" biology" of" the" target," followed" by" progression" to" therapeutic" candidates." As" a"
consequence,"many"of"these"proteins,"by"definition,"contain"deep"grooves"that"are"amenable"to"
binding" by" low"molecular" weight," “drug;like”" small" molecules." For" enzymes," the" substrate" or"
transition" state" can" often" be" used" to" develop" potent" inhibitors." In" contrast," the"modern" shift"
towards"molecular"biology;"and"genomics;based"target"identification"has"often"implicated"other"
types"of" targets," including"nonAenzymes" (Figure"1.1)."Non;enzymes"make"up"a"majority"of" the"
human" proteome" and" they" include" proteins" involved" in" organizing" signaling" pathways,"
maintaining" structural" integrity," assembly/disassembly" of" protein" complexes," chaperoning,"
subcellular" transport," transcription," translation" and" other" critical" functions." Rather" than" using"
enzymatic" turnover" to" carry" out" their" biology," most" non;enzymes" use" protein;protein"
interactions" (PPIs)," either" transient" or" stable" contacts" that" form" the" backbone" of" all" major"
cellular"pathways"(3)."In"turn,"the"challenges"of"targeting"PPIs"have"been"well"documented"(4;6).""
"
Modern"drug"discovery"approaches," such"as"high;throughput"screening" (HTS)," typically" rely"on"
the"measurement"of"enzymatic"turnover"to"drive"discovery"of"potential"clinical"leads;"thus,"non;
enzymes"pose"a"particular"challenge."Rather,"known"“inhibitors”"of"non;enzymes"typically"bind"












Figure" 1.1." Non;enzyme" targets" present" unique" challenges" to" drug" discovery." Classic" enzyme" targets" have" well;
defined"active" sites"and"many"have"clear"allosteric" sites,"which"make"attractive"binding" regions" for"orthosteric"and"
allosteric" inhibitors." In" contrast," most" non;enzymes" lack" obvious" binding" pockets" or" they" are" involved" in" protein;
protein"interactions"that"involve"larger,"more"diffuse"contact"areas.""
"
Despite" these" significant" challenges," the" prominent" role" of" non;enzymes" in" biology" and"
pathobiology" is"certain," so"what"can"be"done"to"expand"the"number"of"“druggable”" targets" to"
include"these"proteins?""What"HTS"methods"can"be"adapted"for"use"against"non;enzymes?"What"
strategies" are" amenable" to" hit" identification" in" the" absence" of" structural" information?" Is" it"
possible"to"identify"a"ligand"binding"site"de(novo?"If"so,"how"can"one"predict"whether"or"not"such"
a" site" is" “druggable”?" In" this" chapter,"we" introduce" small" heat" shock" proteins" as" examples" of"
compelling" but" non;canonical" drug" targets" and" discuss" some" of" the" structural" features" that"
complicate"discovery"efforts"targeting"this"class."We"provide"a"survey"of"the"methods"being"used"





An" intricate" network" of" molecular" chaperones" is" responsible" for" the" maintenance" of" protein"
homeostasis" in" the" cell." Heat" shock" proteins," so" named" because" of" their" characteristic"
upregulation"under"elevated"temperature"stress"conditions,"can"be"classified"as"ATP;hydrolyzing"






sHsps" can" bind" and" sequester" misfolded" client" proteins," effectively" preventing" client" protein"
aggregation" in" an" ATP;independent" manner" (9," 10)." These" non;enzymatic" chaperones" act" as"
proteostasis" buffers" and" maintain" their" substrates" in" a" folding;competent" state" for" the" ATP;
hydrolyzing"chaperone"foldases"to"then"refold"or"otherwise"triage"(11;15)."
"













HspB1" Hsp27" 22.3" Ubiquitous" yes"
HspB2" MKBP" 20.2" Heart,"muscle" no"
HspB3" HspL27" 17.0" Heart,"muscle" no"
HspB4" αA;crystallin" 19.9" Eye"lens" no"
HspB5" αB;crystallin" 20.2" Ubiquitous" yes"
HspB6" Hsp20" 17.1" Ubiquitous" no"
HspB7" cvHsp" 18.6" Heart,"muscle" no"
HspB8" Hsp22" 21.6" Ubiquitous" yes"
HspB9" CT51" 17.5" Testis" no"
HspB10" ODF1" 28.4" Testis" no"




Hsp27," αB;crystallin," Hsp20," and" Hsp22" are" ubiquitously" expressed," while" the" other" sHsps"
exhibit" tissue;specific" expression" (16)." Hsp27," αB;crystallin," and" Hsp22" are" stress;inducible"
under" the" control"of" the" transcription" factor"heat" shock" factor"1" (HSF1)" (18)." These" sHsps"are"
upregulated"in"a"variety"of"stress"conditions,"which"in"many"cases"are"proteotoxic;"these"include"
protein" misfolding," translation" inhibitors," cytoskeletal" stress," or" transport" issues." Heat" stress,"





Figure" 1.2." Alignment" of" primary" sequences" of" six" human" small" heat" shock" proteins," aligned" using" NCBI" Cobalt"
multiple"sequence"alignment"tool."The"red"line"indicates"the"α;crystallin"domain"according"to"(20),"and"the"blue"line"
indicates"the"Hsp27"solution"NMR"construct."The"light"teal"box"demarcates"the"conserved"palindromic"IXI;containing"
motif" important" for" oligomerization." The" grey" box" highlights" the" dimer" interface." Asterisks" indicate" the" sites" of"
mutation"discussed"in"Chapter"2,"and"the"plus"sign"indicates"the"location"of"the"single"endogenous"cysteine"in"Hsp27.""
"
Structurally," sHsps" share" a" characteristic," conserved" α;crystallin" domain" (or" ‘core" domain’)" of"
about" one" hundred" amino" acid" residues" (Figure" 1.2)." This" domain" has" a" β;sandwich"
immunoglobulin;like" fold" and"mediates" dimerization" of" protomers." Stable" α;crystallin" domain"











mediate" oligomerization" (24," 25)." The" C;terminus" also" contains" a" high" proportion" of" charged"
residues" thought" to" be" important" in"maintaining" the" solubility" of" sHsps" (9)." Full;length" sHsps"
6"
"




The" N;terminus" also" contains" serine" residues" that" are" phosphorylated" in" response" to" stress"
conditions" in" the" cell" (27;29)." Upon" phosphorylation," oligomers" dissociate" to" smaller" species,"
and"this"dynamic"regulation"of"oligomeric"size"appears"to"be"coupled"to"chaperone"function"(27;
29)."Both" the"N;terminus"and" the" core"domain"are" involved" in" chaperone" function"and"client;
binding"ability" (9)."Client"binding"sites"have"yet" to"be" fully"characterized,"and"the" field"has"not"
yet" reached" a" consensus" on" what" types" of" conformations" of" sHsps" are" capable" of" binding"
misfolded"or"unfolded"protein"clients"(30)."For"at" least"some"clients," large"oligomers"appear"to"
be" competent" client;binding" conformations." Because" phosphorylation" and" dephosphorylation"
are" required" for" optimal" function" (31)," it" has" been" proposed" that" chaperone" activity" requires"


























































levels"of" sHsps" confer" a" survival" advantage." The"majority"of"our"understanding"of" this"protein"











Amyotrophic" lateral" sclerosis" (ALS)" is" a"multifactorial" neurodegenerative" disease" involving" the"
progressive"death"of"motor"neurons."A"small" fraction"of"ALS"patients"express"mutations" in"the"
enzyme"superoxide"dismutase"1"(SOD1)."In"mouse"models"of"familial"ALS"mutations"(G37R,"G93A"
or" L126Z"mutations" in"SOD1)"αB;crystallin"and"Hsp27"are"upregulated" in" the"affected"neurons"
and" reactive" glial" cells" (38)." In" cultured" mouse" embryonic" fibroblasts," αB;crystallin" co;
immunoprecipitates"with" aggregation;prone"G93A" SOD1"but" not"wild" type" SOD1" (39)." Double"
transgenic" mice" expressing" human" Hsp27" and" G93A" SOD1" have" delayed" motor" neuron"
degeneration"compared" to"SOD1"single" transgenic"mice"during" the"early" stages"of" the"disease"
(40)."Mechanistically,"these"results"suggest"that"sHsps"are"molecular"chaperones"for"destabilized"
Sod1;"consistent"with"this"idea,"both"αB;crystallin"and"Hsp27"suppress"the"aggregation"of"G93A"
SOD1"via" the" formation"of" a" stable" complex" that" is" isolable"by" size;exclusion" chromatography"
(41)." However," the" SOD1" transgenic" mice" do" not" have" extended" lifespans" when" Hsp27" is"
overexpressed" (40)," and" in" the" later" stages" of" the" progressive" disease" Hsp27" levels" decrease"
though"mRNA"levels"are"unchanged"(40;42)."In"two"other"mouse"models"of"ALS"expressing"G37R"
or"L126Z"SOD1,"knockouts"of"αB;crystallin"have"shorter"lifespans"than"the"mice"with"endogenous"
levels" of" αB;crystallin" (43)." Together," these" data" point" to" a" protective" effect" of" sHsps" but"
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possible" saturation" of" sHsp" chaperone" capacity" in" later" stages" of" mutant" SOD1" associated"




Alexander’s" disease" (AxD)" is" a" rare," progressive," and" usually" fatal" childhood" leukodystrophy."
Alexander’s" disease" is" caused" by"mutations" in" glial" fibrillary" acidic" protein" (GFAP)" that" causes"
abnormal"myelin" sheath"development"and" the"accumulation"of" fibrous"proteinacious"deposits"
called"Rosenthal"fibers"in"astrocytes."Hsp27"and"αB;crystallin"are"both"upregulated"in"astrocytes"
of"children"with"AxD"(44)."The"protective,"disease;modifying"role"of"αB;crystallin"in"AxD"has"been"
studied" using" mouse" models" that" conditionally" express" the" chaperone" (44)." Transgenic" mice"
expressing" the" human" GFAP" protein" recapitulate" the" symptoms" of" AxD" and" typically" exhibit"
<10%"mortality"at"30"days"of"age."αB;crystallin"knockouts"in"the"GFAP"transgenic"mouse"exhibit"
significantly" increased" mortality" in" a" gene;dosage" dependent" manner," with" one;third" of" αB;
crystallin+/;"and"two;thirds"of"αB;crystallin;/;"mice"dying"at"32"days."In"the"GFAP"transgenic"mice"
lacking"αB;crystallin," cell;specific" expression"of"αB;crystallin" in" astrocytes"under" the" control"of"
the"GFAP"promoter"recover"the"phenotype,"and"the"majority"of"the"mice" live"to"three"months"










Alzheimer’s" disease" (AD)," the" most" common" form" of" age;related" dementia," is" a" progressive"
neurodegenerative" disease" that" involves" the" aggregation" of" amyloid;β" and" the" microtubule"
stabilizing"protein"tau"(45)."Accumulation"of"protein"aggregates"in"the"brain"leads"to"subsequent"
neuronal" death" and" dementia." Amyloid;β" accumulates" and" forms" senile" plaques," while" tau" is"
hyperphosphorylated," released" from" microtubules," and" aggregates" to" form" neurofibrillary"
9"
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tangles."AD" is" accompanied"by"upregulation"of"Hsp27"and"αB;crystallin," and"Hsp27" is"perhaps"
best" studied" in" the" context" of" this" neurodegenerative" disease" (46)." In" particular," Hsp27"
expression"levels"correlate"with"disease"severity"and"levels"of"phosphorylated"tau"(47,"48),"and"
the"chaperone"activity"of"Hsp27"appears"to"be"protective"in"the"context"of"AD."In"cellular"assays"
using" rat" neuroblastoma" neurons," Hsp27" overexpression" or" adenoviral" delivery" results" in"
decreased" levels" of" hyperphosphorylated" and" total" tau" and" correspondingly" lessened" toxicity"
(31,"48,"49)."Moreover,"in"a"transgenic"mouse"model"of"tauopathy"expressing"the"P301L"mutant"
of" tau" (rTg4510),"adenoviral" transfection"of"Hsp27"rescues" tau;associated"deficits" in" long;term"
potentiation" (31)." Powerfully," transgenic" overexpression" of" human" Hsp27" corrected"
hippocampal" deficits" in" long;term" potentiation" in" a" double;transgenic" mouse" model" of"
Alzheimer’s" disease" that" expresses" the" Swedish" mutation" of" amyloid" precursor" protein" and"
presenilin"1"deleted"in"exon"9"(APPswe/PS1dE9)." In"behavioral"assays"of" learning"and"memory,"
the" transgenic" mice" overexpressing" Hsp27" actually" resembled" normal" wild" type" animals,"
recovering" the" severe" behavioral" phenotypes" seen" in" the" vector" control" animals" (50)."
Mechanistically,"little"is"known"about"how"Hsp27"exerts"this"protective"effect,"though"Hsp27"can"
chaperone" tau" in( vitro( and" prevents" the" elongation" of" tau" fibrils" (31)." Moreover," Hsp27"
preferentially" interacts" with" phosphorylated" versus" unphosphorylated" tau" in"
immunoprecipitation"assays"with" recombinant"protein," suggesting" that" the" chaperone"may"be"
able"to"distinguish"between"the"pathological"and"normal"conformations"of"the"polypeptide"(48).""
"
In" addition" to" its" roles" in" tau" homeostasis," Hsp27" also" plays" a" protective" role" in" amyloid;β"
aggregation" and" toxicity," a" second" major" component" of" AD" pathology" (51," 52)." In" mouse"
neuroblastoma" neurons," Hsp27" is" upregulated" 6;" to" 7;fold"when" the" neurons" are" exposed" to"
toxic" amyloid;β" oligomers." When" the" amyloid;β" oligomers" were" pre;treated" with"
substoichiometric"amounts"of"Hsp27,"Hsp27"completely"abrogated"neurotoxicity,"an"effect"that"
was" specific" to"Hsp27"and"dependent"upon" the"order"of" addition" (that" is," the"effect"of"Hsp27"
was" from" its" interaction"with"oligomers"of"amyloid;β"and"not"directly"with"cells)."Electron"and"
atomic" force" microscopy" suggests" that" Hsp27" remodels" neurotoxic" amyloid;β" oligomers" into"
larger," non;toxic" aggregates" (52)." A" separate" study" demonstrated" a" direct" binding" interaction"
between"Hsp27"as"well"as"three"other"sHsps"with"monomeric"amyloid;β1;40"and"1;42,"and"found"
that" the"apparent" affinity"of" each" interaction" correlated"with" the"degree"of" sHsp" inhibition"of"
amyloid;β" cytotoxicity" and" the" degree" of" sHsp" inhibition" of" amyloid;β" fibril" formation" (53)."
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Together," this"suggests" that"Hsp27’s"chaperone"activity" is" responsible" for"mitigating"toxicity"of"
amyloid;β."
"









40" or" 1;42" and"measured" relatively" tight" (mid;nanomolar)" apparent" affinities,"which"may" reflect"
multivalency" (53)." Third," several" in( vitro" studies" have" shown" that" αB;crystallin" binds" to"
elongating" fibrils" of" amyloid;β1;40" or" 1;42" along" the" lengths" of" fibrils" to" suppress" fibrillization,"
possibly"by"suppressing"fragmentation"and"secondary"nucleation"(56;58)."This"series"of"studies"
indicates" that" αB;crystallin" may" interact" with" multiple" conformations" of" amyloid;β" (i.e."





Parkinson’s" disease" (PD)" is" a" progressive" neurodegenerative" disease" characterized" by" the"




in" the" transgenic" A53T"α;synuclein"mouse." αB;crystallin" inhibits" A53T"α;synuclein" fibrillization"
and"is"thought"to"interact"both"with"partially"folded"monomers"as"well"as"elongating"fibrils"(59,"
60)." Similarly," Hsp27" interacts"weakly" and" transiently"with" α;synuclein" protomers" to" suppress"




susceptibility" of" dopaminergic" neurons" to" A53T" α;synuclein;associated" toxicity." Neurons" with"
increased"expression"of"Hsp27"contain"fewer"Lewy;body;like"aggregates"and"are"protected"from"
A53T"α;synuclein;associated"toxicity"(63)."Consequently,"Hsp27"and"αB;crystallin"may"represent"




Prion" diseases" are" infectious" neurodegenerative" diseases" that" are" transmitted" by" misfolded"
proteins." In" Creutzfeldt;Jakob" disease" (CJD)," a" rapidly" progressing" and" invariably" fatal"
encephalopathy," αB;crystallin" is" highly" upregulated" in" glia" and" neurons" (64," 65)." In" hamsters"
infected"with"the"scrapie"prion,"αB;crystallin"expression"levels"in"reactive"astrocytes"increased"as"
the"disease"progressed" from" the" time"of" inoculation." It" is"not" clear" if"αB;crystallin" is"playing"a"
protective"role"as"a"molecular"chaperone"in"prion"diseases;"however,"because"of"the"similarities"





network" to" restore" proteostasis" is" clear." However," sHsps" are" also" upregulated" in" acute"
neurological" conditions" where" protein" misfolding" is" not" a" central" component" of" the" disease"
etiology;" these" include" epileptic" seizures" and" ischemic" stroke" (66)." Little" is" known" about" the"
involvement"of"sHsps"in"epilepsy,"though"many"studies"have"observed"upregulation"of"sHsps"in"
areas" of" the" brain" where" epileptic" seizures" occur" (67;69)," and" one" study" observed" over" 50%"
reduction" in" kainate;induced" seizure" severity" and" associated"mortality" in" a" transgenic"mouse"







resulting" lesions" by" 44%" compared" to" controls" (72)." In" a" third"model" of" ischemia;reperfusion"
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injury," human" Hsp27" purified" from" human" lymphocytes" was" injected" intravenously" one" hour"
after" the" ischemic" event." The" protein" crossed" the" blood" brain" barrier" and" was" taken" up" by"
neurons"surrounding"the"area"of"ischemic"injury."Treatment"was"accompanied"by"attenuation"of"
neuronal"death;"lesions"were"one;third"of"the"size"of"those"in"untreated"controls"(73)."In"similar"
studies,"mice" lacking"αB;crystallin" exhibited" lesions"nearly" twice" the" size"of" those" in"wild;type"
animals"and" scored" significantly"worse" in"neurobehavioral" tests" following" ischemic" injury" than"
animals" with" endogenous" levels" of" the" chaperone" (74)." In" wild" type" mice," intraperitoneal"
injection" of" recombinant," purified" αB;crystallin" up" to" 12" hours" following" experimental" stroke"
reduced"lesion"volume"by"approximately"half"(74)."It"is"not"clear"whether"the"protective"effect"of"







and" metastasis" and" resulting" in" resistance" to" chemotherapies" (75)." High" levels" of" sHsps" are"
especially" common" in" carcinomas," including" ovarian," breast," head," and" neck" carcinomas," and"
high" levels" of" sHsps" in" tumors" are" associated"with" poor" clinical" prognoses" (75)." In" a" proof;of;




protein;protein" interaction"with"a" specific"effector"of" apoptosis."A" few"studies"have"examined"
direct" interactions" of" sHsps" with" apoptotic" inducers," for" example" cytochrome" C" (77)."
Cytochrome" C" is" released" from" the" mitochondria" in" response" to" apoptotic" signals," and" then"
forms"a"complex"with"several"other"pro;apoptotic"effectors" including"procaspase;9"and"Apaf;1"
(19," 77)," initiating" caspase" cleavage" and" the" beginning" of" apoptosis." Hsp27" interacts" with"






plays" a" role" in"maintaining" cytoskeletal" integrity" by" interacting"with" and"perhaps" chaperoning"
many" proteins" that" make" up" the" cytoskeleton," as" reviewed" in" (78)." Solid" tumor" metastasis"
requires" an" epithelial;to;mesenchymal" transition," invasion" of" cancer" cells" into" other" tissues,"
then" reversion"back" to"epithelial" cells" and" subsequent"adhesion"and"growth."Both" transitional"
processes" involve" dramatic" cytoskeletal" remodeling," so" it" has" been" hypothesized" that" the"
requirement" of"Hsp27" for" tumor"metastasis" involves" its" chaperoning" of" cytoskeletal" elements"
(19," 78)." Though" more" work" remains" to" be" done" to" understand" the" mechanism" of" sHsp"







the" high;throughput" screening" assays" that" rely" on" enzymatic" turnover" as" a" reporter."
Additionally," sHsps" do" not" have" endogenous" cofactors" or" tight" binding" natural" ligands," and"
correspondingly"there"are"no"known"ligand"binding"sites."While"sHsps"are"known"to"engage"in"a"
number" of" protein;protein" interactions" (recently" reviewed" in" (78))," these" are" largely" transient"
and" weak" interactions" that" are" poorly" suited" for" the" design" of" a" high;throughput" screening"
platform."To"make"matters"worse,"oligomeric"sHsps"are"very"large"(>500"kDa)"and"polydisperse,"
and"are"consequently"very"difficult"problems"for"structure;based"design."As"discussed"earlier"in"
this" chapter," genetic" proof;of;concept" studies" suggest" that" sHsps" may" represent" attractive"
therapeutic" targets" in" a" number" of" indications." However," to" date" these" studies" have" all"
examined" the"phenotypic" effects" of"modulating" total" levels" of" protein," rather" than" tuning" the"
function" of" sHsps" at" endogenous" levels." An" sHsp" modulator" might" act" at" the" level" of"
transcription" to" change" total" levels" of" sHsp," for" example"by"modulating"HSF1" activation."With"
this"goal" in"mind,"pilot" studies" involving" targeting"HSF1"with"small"molecules"were"carried"out"
and" are" described" in" the" Appendix" of" this" thesis." Conversely," a" small" molecule" may" act" by"
directly"engaging"an"sHsp"or"sHsp;client"complex"and"tuning"chaperone"function"at"the"protein"






sHsps," given" the" incomplete" mechanistic" understanding" of" structure;function" relationships" in"
this"class"of"proteins."A"useful"sHsp;based"therapeutic"for"neurodegeneration"would"agonize"the"
protein’s" chaperone" activities," which" are" protective" in" these" disease" states." An" sHsp" agonist"
could" stabilize" sHsp;client" interactions" or" favor" active" conformations" of" sHsps" that" are"
competent" to"bind" clients." Conversely," an" sHsp"antagonist"would"be"useful" in" cancers,"where"
inhibition"of"sHsp"chaperone"function"is"desirable."A"molecule"that"inhibits"sHsp;client"protein;








sHsps"have"been"genetically"validated"as"promising" therapeutic" targets."However," this" class"of"
proteins"has"been"labeled"‘undruggable’"because"of"a"number"of"aspects"of"sHsp"structure"and"
function"that"preclude"application"of"many"of"the"common"strategies"for"drug"discovery"to"this"
family" of"molecular" chaperones." Thus," this" class" of" proteins"may" be" considered" as" genetically"






difficult" to" identify" molecules" that" bind" the" target.( In" the" absence" of" an" enzymatic" function,"
there" is" no" convenient" surrogate" for" ligand" binding," so" the" interaction" must" be" directly"
measured.(Nuclear(magnetic( resonance( (NMR)Abased( screening" has"proven" to"be"particularly"
amenable" to" the" label;free," affinity;based" selection" of" ligands" that" bind" a" target" of" interest,"
including"non;enzymes"(79)."The"most"information;rich"platform"for"NMR;based"screening"uses"
a" two;dimensional" experiment" (HSQC" or" TROSY)" and" observes" 15N" or" 13C" isotopically" labeled"





assigned" to" the" protein’s" primary" sequence," then" the" ligand" binding" site" may" be" directly"
determined"from"this"experiment."The"binding"site"is"often"used"to"prioritize"hits"and"the"screen"
may"be"carried"out"in"the"presence"of"a"competitive"orthosteric"ligand"to"favor"the"identification"
of" second;site" binders." False" positive" rates" are" typically" low," and" nonspecific" binding" is" often"
readily" recognizable." However," protein;observed" NMR" screening" requires" that" the" protein" be"
highly"soluble,"stable,"and"homogenous"at"high"concentrations"(50"to"500"μM"(80)),"able"to"be"
recombinantly"expressed""in"isotopically"enriched"media,"and"relatively"small"(less"than"~80"kDa,"
though" this" limit" depends" on" the" type" of" labeling" and" experiment" used" (81))." Thus," to"
complement"the"protein;observed"experiments,"a"number"of"one;dimensional,"ligand;observed"
experiments" may" also" be" used," including" saturation" transfer" (82," 83)" and" diffusion" based"
experiments" (84," 85)." These" approaches" are" selection;based," meaning" that" only" the" ligands"
interacting"with" the" target"protein" are" identified" from"mixtures." Ligand;observed"experiments"
require"relatively"low"concentrations"of"protein"(typically"1"to"10"μM),"and"the"protein"need"not"
be" isotopically" labeled." In" addition," they"have"higher" throughput" and" lower"experimental" cost"
than" protein;observed" experiments." However," ligand;observed" methods" do" not" distinguish"
between"specific"and"nonspecific"interactions,"they"offer"no"information"on"the"binding"site,"and"
they"suffer"from"higher"false"positive"rates"(though"the"combination"of"several"ligand;observed"
experiments" may" increase" reliability" (86))." For" both" ligand;" and" protein;observed" NMR"
experiments," relatively" weak" interactions" (KD" values" between" 0.1" μM" to" 10" mM)" can" be"
measured,"but"stronger"interactions"can"give"false"negatives"(81)."
"
In" addition" to" its" utility" as" a" screening" strategy," NMR" can" be" extremely" valuable" for" de( novo"
binding" site" identification" in" targets" for" which" no" orthosteric" site" is" known" or" for" which" an"
allosteric" site" is" desired" (87;91)." These"methods"might" even" reveal" sites" that" are" not" obvious"
from" available" crystal" structures" because" NMR" is" solution;based." Because" of" the" reliability" of"
NMR" in" identifying" binding" sites" for" small" molecules," hit" rates" from" fragment;based" NMR"






affinity" (<300"nM)"among"a"set"of"23"protein" targets" (92)."This"approach"might"be"particularly"




To" illustrate" the" potential" of" NMR;based" screening" campaigns," it" is" useful" to" consider" the"
specific"example"of" survivin." Survivin" is"a" cell" cycle" regulator"and" inhibitor"of"apoptosis" that" is"
upregulated"in"most"tumor"cell"types"but"absent"in"most"other"adult"tissues"(95)."High"levels"of"
survivin" have" been" associated" with" poor" prognosis" in" patients" (96)" and" antisense"
oligonucleotides" and" siRNA" against" survivin" decrease" proliferation" in" a" number" of" cancer" cell"
lines" (97," 98)." Survivin" has" no" enzymatic" activity" or" known" endogenous" small" molecule"
regulators," and," accordingly," no" robust" biochemical" assay" of" survivin" function" has" been"
established."Wendt"and"colleagues"at"Abbott"Laboratories"chose"to"employ"two"complementary"
affinity;based" screening" methods,( NMRAbased( screening" and" affinity( selection( mass(
spectrometry( (ASAMS)( to" pursue" lead" generation" of"molecules" that" bind" survivin" (79)." AS;MS"
experiments"start"with"the"incubation"of"a"mixture"of"ligands"with"the"protein"target"of"interest,"
followed" by" a" separation" step" to" remove" unbound" molecules" and" mass" spectrometry;based"
identification"of"eluted"compound(s)"(99)."These"methods"are"highly"sensitive"and"allow"for"the"
evaluation"of" large"chemical" libraries"(up"to"108"to"date," (100))"without"the"need"to"add" labels"
(99," 101)." However," because" it" is" prone" to" false" positives," this" method" is" complemented" by"
protein;based"NMR"screening."Thus,"the"Abbott"group"used"these"two"methods"in"combination"
to"discover"a"novel"small"molecule;binding"site"on"the"dimer"interface"of"survivin."They"also"used"
the" relative"hit" rates" from"the"screening"campaign" to"evaluate" the" relative"druggability"of" this"
new"site,"concluding" that" the"dimer" interface"may"be"particularly"promising" (0.35%"relative" to"
0.01%" for" a" known" peptide;binding" interface)." One" lead" series" was" developed" into" a" class" of"
compounds" with" nanomolar" affinity" for" survivin" (79)." Although" it" is" not" yet" clear" how"
interactions" with" this" binding" site" impact" survivin" biology," the" lead" compounds" from" this"
campaign"are"expected"to"be"powerful"probes"for"target"validation.""
"
Surface( plasmon( resonance( (SPR)( is" a" label;free" platform" for" the" detection" of" direct" binding"
interactions." Briefly," the" target" protein" is" typically" immobilized" to" a" gold" chip," and" potential"
ligands" are" introduced" to" this" surface." Real;time" association" and" dissociation" rates" of" the"
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with" newer" generations" of" the" technology;" the" latest" instrument" from" GE" Healthcare," the"
Biacore"4000,"handles"up"to"4,800"samples"per"day"(103)."However,"this"technique"is"still"more"
widely" applied" to" the" evaluation" of" small," focused" libraries" during" lead" optimization." Some"










to"modified"glass"microscope"slides," followed"by" incubation"with"the"protein"target"of" interest"
that"is"either"directly"labeled"with"a"fluorophore"or"detected"using"a"fluorescent"antibody"(Figure"
1.5A)." This" approach" has" been" used" to" discover" new" ligands" for" non;enzymes," including" the"
yeast" transcription" factor" Hap3p" (105)" and" the" extracellular" signaling" protein" Sonic" hedgehog"
(106)." In" the" Hap3p" campaign," a" collection" of" 12,400" immobilized" compounds" was" screened,"
leading" to" the" discovery" of" haptamide" B." Haptamide" B" binds" Hap3p" and" inhibits" its"
transcriptional" activity" (105)," likely" by" blocking" PPIs" in" the" transcription" complex." In" a" similar"










Tethering( is" a" technique" that" uses" disulfide" exchange" to" identify" small"molecule" ligands" for" a"
given"site"on"a"protein"(111)."This"technique"enables"discovery"targeting"orthosteric"or"allosteric"
sites." Such" sites" may" be" apparent" from" prior" structural" knowledge" of" the" target" and" its"
mechanism"of"action,"or"may"be" identified(de(novo(using"computational"methods" (see"section"
1.10)." Tethering" may" also" be" applied" to" the" inhibition" of" protein;protein" interactions," which"
often" involve" large," diffuse" surfaces" of" the" binding" partners" (5)." In" these" instances," alanine"
scanning"may"be"useful" in" identifying"‘hot"spots’"on"a"protein"surface"that"account"for"most"of"
the" binding" energy" (112)," which" may" then" be" targeted" for" inhibitor" binding." In" disulfide"
tethering," a" cysteine" residue" is" introduced"within" or" adjacent" to" the" site" of" interest," and" any"
endogenous"reactive"cysteines"are"mutated"to"alanines."The"target"protein"is"then"exposed"to"a"
library" of" small"molecules" (generally" fragments)" containing" reactive" thiols," in" the" presence" of"
competing"amounts"of"a"thiol" reducing"agent"such"as"β;mercaptoethanol."A"molecule"that"has"
favorable" physicochemical" interactions" with" residues" in" the" site" will" outcompete" β;
mercaptoethanol( and" form" a" mixed" disulfide" adduct" with" the" protein" target." The" resulting"
‘tethered’"protein;ligand"adduct"can"then"be"identified"by"mass"spectrometry"(111)."Hits"from"a"
tethering" screen" may" be" elaborated" and" optimized," using" structure" guided" design" and"
competition"with"β;mercaptoethanol"as"a"proxy"for"affinity."The"thiol"in"the"ligand"can"then"be"
removed"or"replaced"and"the"ligand"will"retain"affinity"for"the"wild;type"target"protein."In"some"
cases," tethering" can" be" used" to" target" endogenous" cysteines;" the" thiol" in" the" ligand"may" be"





Monitoring" ligand;induced" changes" in" protein" stability" is" another" way" to" discover" potential"
ligands"for"non;enzymes."Historically,"the"drug"discovery"applications"of"ligand;induced"stability"
were" pioneered" in" attempts" to" develop" “pharmacological" chaperones”," or" molecules" that"
stabilize" the" folded" form"of"a"mutated"or"damaged"protein."Pharmacological"chaperones"have"
been"successfully"used"to"correct"disease"phenotypes"in"a"number"of"disorders"caused"by"a"loss"
of"protein"stability"(114),"including"phenylketonuria"(115,"116),"Gaucher"disease"(117,"118),"Tay;




amyloidosis," familial" amyloid" polyneuropathy" (124)." Tafamidis" kinetically" stabilizes" the"
tetrameric"conformation"of"transthyretin,"increasing"the"activation"barrier"of"dissociation"of"the"
tetramer" to" an" unstable"monomer" (122)." Similarly," a" recently" discovered" peptide" inhibitor" of"
caspase;6"acts"by" stabilizing"an" inactive," tetrameric" conformation"of" the"protein" (125)."Recent"




not" rely" on" enzymatic" turnover," they" are" particularly" versatile" tools" for" discovery" in" a" post;
genomic"era."
"
Differential( scanning( fluorimetry" (DSF)" is" one" technique" for" measuring" the" ligand;induced"
changes" in" the" thermal" stability"of"a"protein" (128)." In" these"experiments," a"protein" solution" is"
heated," leading"to"thermal"denaturation."This"unfolding"is"monitored"using"an"environmentally"








molecule"microarray" indicate" the"presence"of" a" fluorescently" labeled"protein"bound" to" the" immobilized" ligands." B:"
Differential" scanning" fluorimetry"measures"changes" in" the"melting" temperature" (Tm)"of"a"protein" target" induced"by"







is" a" tumor" suppressor" that" normally" functions" to" regulate" cell" cycle" arrest" and" apoptosis."
Knockout"mice"(p53;/;)"have"high"rates"of"spontaneous"tumors,"and"p53"null"or"mutant"tumors"
are" associated" with" poor" prognosis" and" resistance" to" chemotherapy" in" a" number" of" human"
cancers" (133)." The" suppressor"oncogenes"MDM2"and"HDM2"engage" in"PPIs" that" activate"p53,"
leading" to" cell" cycle" arrest" and"apoptosis." These"observations" suggested" that" inhibitors"of" the"
p53;MDM2/HDM2"interactions"might"be"promising"anti;tumor"agents,"yet"the"drug"target"was"
clearly"a"non;enzyme,"PPI"interface."A"team"at"Johnson"&"Johnson"used"DSF"to"screen"a"focused"
collection" of" 22,000" 1,4;benzodiazepine;2,5;diones" for" affinity" to" HDM2" (134," 135)." The"
screening" hits" were" then" evaluated" for" inhibition" of" the" p53;HDM2" PPI" by" a" competitive"
fluorescence"polarization"(FP)"assay,"resulting"in"the"development"of"inhibitors"with"nanomolar"
potency"in"cancer"cell"lines"(133)."In"this"example,"the"candidate"molecules,"discovered"by"DSF,"
appear" to"bind"HDM2"and"stabilize"a"conformation"that"prevents" the"p53" interaction."DSF"has"
more"recently"been"applied"to"an"HTS"campaign"against"the"F508Δ"mutant"of"the"cystic"fibrosis"
transmembrane"conductance"regulator"(CFTR)"(136)."This"point"mutant" is"responsible"for"most"
cases" of" cystic" fibrosis" and" it" is" known" to" destabilize" the" protein," causing" F508Δ" CFTR" to" be"
aberrantly" retained" in" the" ER" and" degraded" rather" than" trafficked" to" the" plasma"membrane,"
where" it" normally" functions"as" a" chloride" channel."DSF"was"used" to"prioritize"hits" from"a" cell;
based" primary" screen" and" it" was" found" that" the" most" promising" molecules" bind" to" the" first"
nucleotide;binding"domain"of"the"CFTR,"helping"to"restore"the"folding"free"energy"(ΔG)" lost"by"
the"mutant."These"efforts"resulted"in"the"identification"of"a"phenylhydrazone,"RDR1,"which"acts"
as" a" pharmacological" chaperone" for" the"misfolded" F508Δ"CFTR"mutant" (136)."My"attempts" to"
adopt" this" approach" to" study" Hsp27" and" αB;crystallin" will" be" discussed" in" Chapter" 3." Finally,"
several"variations"of"DSF"experiments"have"been"reported."For"example,"intrinsic"fluorophores,"
such" as" tryptophan" or" a" cofactor," can" be" used" in" place" of" an" extrinsic" dye" (137);" cysteine"
residues" can" be" used" in" combination" with" thiol;specific" fluorochromes" in" the" same" manner"
(138).""
"




protein" is" placed" in" buffer" containing" deuterated" water," exchangeable" protons" on" amide"
nitrogens"and"side"chain"heteroatoms"are"replaced"with"deuterons"at"a"rate"that"is"proportional"
to" their" relative" solvent" accessibility."Upon"unfolding" of" the" protein," internal" protons" become"
exchangeable"(139),"thus"ligands"can"be"detected"by"their"ability"to"delay"or"prevent"deuteration"
(Figure" 1.5B)" (140)." This" technique" has" been" developed" for" HTS" by" the" Fitzgerald" laboratory"
using"the"prolyl"isomerase"cyclophilin"A"as"a"model"system"(141;143)."In"this"example,"a"library"




Another" tool" in" the" discovery" of" ligands" for" non;enzyme" targets" is" de! novo( binding( site(
identification," which" uses" geometrical," energy;based," evolutionary," or" probe" mapping"




sites" by" identifying" concave" ‘pockets’" on" the" surface" of" a" rigid" protein" structure" (144)."
Alternatives" include" energy;based" approaches," which" use" a" 3D" potential" grid" to" identify"
contiguous" regions" of" predicted" low" energy" interactions" (146)" and" evolutionary" (or" genomic)"
methods,"which"consider"the"degree"of"conservation"of"amino"acids"on"a"protein’s"surface"(145,"





rigid" protein" structure,"which"makes" them" fast" but" inaccurate" for" flexible" binding" sites" (145)."
However," one" recent" advance" is" based" on" the" multiple;solvent" crystal" structure" (MSCS)"
approach"(148)."In"the"MSCS"experiment,"a"target"protein"is"crystallized"and"placed"in"solutions"
containing"organic"solvent."The"organic"probes"displace"water"and"they"tend"to"accumulate"at"
sites" where" favorable" interactions" may" be" possible." When" multiple" solvents" are" used," the"
contributions" of" aromatic," aliphatic," and" hydrogen" bonding" interactions" are" identified" (Figure"




experiments" in" a" virtual"box"of"mixed"aqueous"and"organic" solvent"molecules" (e.g."benzene"+"
propane"+"water)." This" system" is"minimized" in"a"molecular"dynamics" (MD)" simulation" to"build"







stages," a" number"of" interesting" studies"have"been" reported" (150;153)." Briefly," these"methods"
use" a" combination" of" physical" and" physicochemical" parameters," including" the" shape," size,"
hydrophobicity,"and"hydrogen"bonding"capability"of"the"pocket,"and"they"compare"these"values"
to" training" sets" of" known" ligand;protein" pairs." Cheng" et( al.( developed" one" such" method" for"
predicting"maximal"affinity"using"a" scoring" system"based"on" the"hydrophobicity"of" the" solvent"
accessible"surface"area"(SASA)"and"the"shape"(curvature)"of"the" ligand"binding"sites" (150)."This"
method"was" able" to" confirm" approximately" 60" known"protein;ligand"maximal" affinities."More"
importantly," they" also" carried" out" pilot" screens" of" 11,000" compounds" against" two" target"
enzymes,"one"of"which"was"predicted" to"be"“druggable”" (i.e." good"maximal"affinities)"by" their"
computational" method" and" the" other" “difficult”" (i.e." weak" maximal" affinities)." These" screens"
gave" hit" rates" of" 1.8%" and" 0.15%," respectively," consistent" with" the" prediction." Moreover,"
additional" optimization" at" Pfizer" produced" eleven" sub;micromolar" potency" leads" from" the"








more" complex" topology" (e.g." macrocycles," high" number" of" chiral" centers)" than" inhibitors" of"
traditional," enzyme" targets" (recently" reviewed" in" (159))." Thus," the" success" of" HTS" for" non;
23"
"
canonical" targets" may" be" critically" dependent" on" the" selection" of" the" appropriate" chemical"
library" and" seemingly" failed" screens" for" non;enzymes" may," in" fact," have" arisen" from" poor"
sampling"of"chemical" space."Consequently," creative"construction"of"new"chemical" libraries" is"a"
vibrant" and" important" area" of" research" that" is" likely" to" expand" our" definition" of" “druggable”"
targets.""
(
DiversityAoriented(synthesis" (DOS)" is"one"approach" to"expand" the"chemical" space" sampled"by"
synthetic" chemical" libraries." Many" current" HTS" libraries" consist" of" molecules" representing" a"
relatively" small" number" of" chemical" scaffolds," with" physicochemical" properties" resembling"
existing"drugs"(156)."DOS"approaches"rely"on"divergent"synthetic"steps,"in"which"the"product"of"
one" complexity;generating" transformation" is" a" substrate" in" a" second," and" so" on" (160;162)"
(Figure" 1.6A)." Thus," in" contrast" to" target;oriented" synthesis" or" medicinal" chemistry," DOS"










these" natural" compounds" tend" to" be" more" structurally" complex," with" more" chiral" centers," a"
higher" proportion" of" carbon," hydrogen," and" oxygen" atoms" and" fewer" nitrogen" atoms" than"
synthetic"compounds"(reviewed"in"(165))."They"also"tend"to"be"larger"(>"500"Da)"and"frequently"
more"water;soluble" (166)." These" compounds"have"evolved" to"be"bioactive;" thus," they" tend" to"





on" privileged( core( natural( products( have" been" constructed" around" a" number" of" scaffolds,"
including"carbohydrates,"steroids"and"sterols,"fatty"acid"derivatives,"polyketides,"linear"and"cyclic"
peptides,"terpenoids,"flavonoids,"alkaloids,"macrolactones"and"macrolactams,"and"many"others"
(165)" (Figure" 1.6B)." In" a" related" concept," Hopkins" and" Groom" presented" the" idea" that" the"
majority"of" drugs" compete"against" endogenous" small"molecule" regulators" for"binding" sites"on"




Another" interesting"property"of"natural"products" is" that" they"can"sometimes" inhibit"otherwise"
intractable" classes" of" drug" targets," such" as" PPIs" (172)." " For" example," we" recently" screened" a"
small" library" of" plant;derived" natural" products" and" successfully" identified" inhibitors" of" the"
challenging"PPI" between" the" anti;bacterial" targets"DnaK"and"DnaJ" (173," 174)." The"difficulty" of"
targeting" PPIs" using" commercial" libraries" is" thought" to" result," in" part," from" incompatible"
physicochemical"properties"(94,"158)."For"example,"a"2010"analysis"compared"66"PPI" inhibitors"





Ribosomal" and" non;ribosomal" peptides" are" natural" products" that" exhibit" a" wide" range" of"
biological" activities." Synthetic" peptides" are" often" assembled" by" solid" phase" synthesis," using"
functionalized"polystyrene"resin"beads"as"solid"support."Natural"and"unnatural"amino"acids"may"
be"modularly"incorporated"to"rapidly"assemble"a"large"amount"of"diversity"using"split;and;pool"
methods." In"one;bead;one;compound" combinatorial" libraries," each" solid;support" resin"bead" is"
coated"with"a"homogenous"population"of"a"unique"peptide"or"peptoid"(176;178)."Such"libraries"
can" then"be" incubated"with"a" fluorescently" labeled" target"of" interest" to" find"binding"partners."
Like"other"affinity;based"selection"techniques,"such"as"phage"display"(179),"this"platform"can"be"
applied"to"any"type"of"target"molecule,"even"non;enzymes"(177)."Linear"peptides"generally"have"
poor" pharmacokinetic" properties" (poor" absorption" and" susceptibility" to" rapid" degradation" by"
proteases)," but" this" can"be" circumvented"using" a" number" of"well;established" strategies" (180)."
25"
"
For"example," synthetic(biological(agents" such"as" stapled"peptides"with" covalently" constrained"
secondary" structure" may" be" cell;permeable" and" resistant" to" cellular" proteases" (181," 182)."
Moreover," the" conformational" restriction" imposed" by" the" covalent" stabilization" of" secondary"
structure" can" efficiently" mimic" the" binding" surface" of" a" protein" (most" notably" α;helices),"
resulting"in"tight"and"productive"binding."Stapled"peptides"have"been"successfully"developed"to"
modulate"a"number"of"noncanonical" targets" such"as" transcription" factors"as"well"as"PPIs" (183;
185).( Cyclic( peptides( are" another" class" of" natural" products" suitable" for" use" in" targeting" non;
enzymes."The"reduced"conformational"flexibility"of"cyclized"peptides"is"advantageous"for"target"
binding," membrane" permeability," and" stabilization" against" digestion" by" endoproteases" (186)."
Until" recently," the" one;bead;one;compound" technique" was" limited" to" the" screening" of" linear"
peptide" or" peptoid" libraries," because" Edman" degradation" sequencing" requires" a" free" amino"
terminus." However," Liu" et" al." developed" a" clever" strategy" to" circumvent" this" obstacle" (186),"




screen" of" a" focused" library" of" over" 106" cyclic" peptides" designed" to" competitively" inhibit" the"






are" identified" by" PCR" amplification" and" sequencing" of" the"DNA" tag." DELs"may" be" synthesized"
using" split;and;pool" combinatorial" assembly" or" DNA;templated" synthetic" methods" (188)." For"
example,"Wrenn"et(al."synthesized"and"screened"108"DNA;encoded"8;mer"peptoids" for"binding"
to" the" N;terminal" SH3" domain" of" the" proto;oncogene" Crk" (p38)" (100)," which" successfully"
resulted" in" the" identification"of" several" peptoids"with" low;" to"mid;micromolar" affinity" for"Crk."
One" drawback" of" this" approach" is" that" synthetic" transformations" used" in" library" construction"











past" decade" (191)," and"provides" several" strategic" advantages." First," fragment;based" screening"
libraries"exhibit"high(sampling(efficiency;" they"offer"greater"coverage"of"chemical"space"with"a"
smaller"number"of"library"members"(192)."In"fact,"a"library"of"103"fragments"represents"the"same"
chemical" space"as"1013"drug;like"molecules" (192)." Second," fragment"based" screening"produces"
weak(but(high9quality(binders."Absolute"binding"affinities"range"from"micromolar"to"millimolar,"




half" of" the" binding" energy" to" an" optimized," nanomolar" KD" molecule" (193)," as" long" as" the"












To" illustrate" these" concepts,"my" thesis" is" focused"on" using" a" full" suite" of"modern"methods" to"
develop" molecules" that" bind" sHsps." Because" of" their" complex" structures," these" proteins" are"






molecule" in( vitro" and" in" animal" models" of" disease." This" work" was" carried" out" in" close"
collaboration"with"the"Andley"laboratory."Chapter(4"describes"orthogonal"discovery"efforts"that"
resulted" in" the" identification" of" ligands" for"Hsp27"despite" its" absence" of" enzymatic" activity" or"
known"small"molecule"binding"sites;"this"work"was"carried"out" in"collaboration"with"the"Klevit,"
Carlson,"and"Cierpicki"laboratories."Chapter(5"is"a"discussion"of"future"work"required"to"continue"





























































































































































































































































































































































































































































































































































































proteostasis! network.! These! proteins! bind! to! destabilized! client! proteins! and! prevent! offB
pathway!aggregation,!maintaining!a! foldingBcompetent!state! for!enzymatic!components!of! the!
chaperone! network! to! refold! or! triage! (6,! 7).! Structurally,! sHsps! have! a! conserved! core! αB
crystallin! domain! that!mediates! dimerization! via! an! antiparallel! βBstrand! interface! (8,! 9).! This!
core!domain!is!flanked!by!less!conserved!NB!and!CBterminal!extensions!that!permit!sHsp!dimers!





























Amyloids! are! ordered,! insoluble! protein! aggregates! that! are! formed! when! unstable! protein!
monomers! adopt! a! ‘crossBβ’! rich! structure! and! stack! together! in! higherBorder! filaments!




is! granted!by! secondary! interactions! involving! steric! intercalation!of! side! chain! residues! in! soB
called! ‘steric! zippers’! that! exclude! water! (23,! 24).! Amyloid! deposits! are! classically! associated!
with! Alzheimer’s! disease,! in! which! they! were! first! discovered,! but! an! increasing! number! of!
human!diseases! in!other!organs!have!been! linked! to!amyloid!deposition!as!well! (23).! In! these!
diseases,! protein!misfolding! is! thought! to! cause! toxicity! by! overwhelming! the! capacity! of! the!
chaperone!and!degradation!machineries!to!maintain!proper!protein!homeostasis.!This!results!in!











Protein( Mutation( Region( Disease( Known(effects(
Hsp27!
(HSPB1)!
G34R! NT! DHMN! Uncharacterized!
P39L! NT! CMT2!and!DHMN!(AD)! Uncharacterized!














S135M! ACD! CMT2!and!DHMN!(AD)! Uncharacterized!
R136W! ACD! CMT2!(AD)! Increases!binding!to!tubulin!




K141N! ACD! PN!(AD)! Uncharacterized!
K141Q! ACD! PN!(AD)! Mutation!decreases!melting!temperature!(28)!
T151I! ACD! DHMN!(AD)! Uncharacterized;!does!not!increase!monomerization!or!binding!to!tubulin!(1,!27)!!







P182S! IXI!motif! DHMN!(AD)! Uncharacterized!




R12C! NT! Cataract!(AD)! Increases!oligomeric!size!and!alters!secondary!structure!(29);!aggregates!in!cells!(22)!
R21L! NT! Cataract!(AD)! Alters!secondary!structure!(29);!aggregates!in!cells!(22)!


































R11H! NT! Cataract!(AD)! Alters!secondary!structure,!decreases!surface!hydrophobicity,!induces!apoptosis!(40)!
P20S! NT! Cataract!(AD)! May!affect!phosphorylation!(located!next!to!Ser19)!
R56W! NT! Cataract!(AR)! Uncharacterized!


























R157H! IXI!motif! DCM!(AD)! Increases!interaction!with!titin,!aggregates!in!cells!(22)!












































































































R120G αB-crystallin (0.25 mg/mL)
αB-crystallin
R120G αB-crystallin (0.5 mg/mL)












R120G αB-crystallin (0.25 mg/mL)
αB-crystallin


























Protein Tm (°C) SEM n 
αB-crystallin 60.0 0.19 6 
R120G αB-crystallin 63.9 0.35 6 
Hsp27 70.3 0.23 6 











































































more! susceptible! to! proteolysis! and! melts! at! a! lower! temperature! (64.0!±!0.2! versus!
69.8!±!0.2!°C! (28)).!However,! its!aggregation!propensity!has!not!been! reported.!We!wanted! to!
investigate!the!amyloidBforming!propensity!of!R140G!Hsp27!to!see!if! it!behaves!analogously!to!
R120G! αBBcrystallin.(We! expressed! and! purified! Hsp27! containing! the! R140G! mutation! and!
measured! its! thermal! stability! by! DSF.! In! good! agreement! with! the! literature,! R140G! Hsp27!
appeared! to!be!slightly! less! stable! than! the!wild! type!protein,!melting!with!an!apparent!Tm!of!
65.9! ±! 0.10! °C! versus! 70.3! ±! 0.23! °C! (Figure!2.5).!Using! light! scattering,!we! found! that!R140G!
aggregated!under!relatively!mild!conditions!at!physiological!pH!with!mild!heating,!though!the!lag!















































































































































In!2004,! Evgrafov!et! al.! reported! the! identification!of! a!mutation!S135F! in!Hsp27! in!a!Russian!
family!with!CharcotBMarieBTooth!disease! (14).!A!cohort!of!301! individuals!with!CharcotBMarieB
Tooth! disease! and! 115! individuals! with! distal! hereditary! neuropathy! were! subsequently!
screened! for! mutations! in! the! same! gene,! and! four! additional! missense! mutations! were!
identified! (R127W,! R136W,! T151I,! and! P182L;! see! Table! 2.1).! The! five! mutations! segregated!
! 53!
perfectly!with!disease!phenotypes!and!were!absent!in!200!healthy!controls!(14).!Some!evidence!
was! reported! that! suggests! the! R127W! and! S135F! mutations! in! Hsp27! may! destabilize! its!
dimeric! βBsandwich! substructure,! leading! to! its! aggregation! and! gain! of! toxic! function!
phenotypes.! In! SHBSY5Y! and! HEK293! cells,! the! transfected! Hsp27! mutants! R127W! or! S135F!
appeared!to!reduce!the!ability!of!the!protein!to!form!disulfideBcrosslinked!dimers!(1).!Because!of!
this,!we!wanted!to!examine!the!effect!of!these!mutations!on!the!structure!and!stability!of!the!





The!R127!residue! is! located!on!the! loop!between!the!β5!and!β6+7!strands,!and! ion!pairs!with!
H102! from! the! same! protomer,! located! on! the! adjacent! loop! formed! from! the! β3! and! β4!
strands.! In! the! core! domain! structures,! the! R127! residue! is! solvent! exposed,! but! the!





We! used! siteBdirected! mutagenesis! to! introduce! the! R127W! mutation! into! the! core! domain!
construct!of!Hsp27.!By!differential!scanning!fluorimetry,! its!stability!was!very!similar!to!that!of!
the!wild! type! core! domain! (53.8! ±! 0.04! °C! versus! 53.4! ±! 0.038! °C,! respectively).! However,! by!
HSQC!it!appeared!that!the!native!fold!of!the!protein!was!compromised.!In!contrast!to!the!R140G!
Hsp27! core! domain! spectrum,! the! R127W! spectrum! is! missing! about! half! of! its! crossBpeaks,!
suggesting!that! its!native! fold!may!be!very!different! than!that!of! the!wild! type!protein! (Figure!
2.11).! Indeed,!when! a! solution! of! 1!mg/mL! R127W!Hsp27! core! domain! in! sodium! phosphate!
buffer!at!physiological!pH!was!gently!heated!for!one!hour!at!46!°C,!extensive!aggregation!was!
observed! by! electron!microscopy! (Figure! 2.12).! Conversely,! grids! of!wild! type! protein! did! not!
show!appreciable!aggregation.!Given!the!rapid!aggregation!behavior!observed!for!R127W!core!
























the! β6+7! strand! that! forms! the! antiparallel! dimer! interface! of! Hsp27.! Its! side! chain! forms! a!
hydrogen! bond! with! a! backbone! carbonyl! group! across! the! dimer! interface,! presumably!
contributing!to!the!stability!of! the!dimer.!Mutation!of! this!serine!to!a!phenylalanine!would!be!




48.8! ±! 0.56! °C! relative! to! 53.4! ±! 0.038! °C! for! the! wild! type! core! domain.! This!mutation! was!
accompanied! by! even! more! dramatic! changes! to! the! HSQC! spectrum! of! the! protein! (Figure!







Interestingly,! S135F!also! increases! the!aggregation!propensity!of! the! core!αBcrystallin!domain,!









This! suggests! that! the! R127W! and! S135F! mutations! destabilize! the! core! domain! of! Hsp27,!
resulting! in! protein! aggregation.! These! mutations! may! also! cause! protein! aggregation! in!
diseased! neurons,! contributing! to! gainBofBtoxic! function! pathology! in! CharcotBMarieBTooth!
disease! and!distal! hereditary!peripheral! neuropathy.! Together,! this! leads! to! a!model! in!which!







associated!mutations! R127W! and! S135F! alter! the! native! tertiary! structure! of! the! protein! and!
result! in! accelerated!protein! aggregation.!Each!of! these!mutations! appear! to! compromise! the!
stability!of! the!dimer! interface,! leading! to!a!model! in!which!sHsp!monomers!may!misfold!and!
form! ordered,! βBsheet! rich! amyloid! fibrils.! For! the! hot! spot! residues,! the! loss! of! two! interB
protomer! salt! bridges! destabilizes! the! dimer;! for! S135F,! it! is! the! loss! of! two! interBprotomer!
hydrogen! bonds.! A! molecular! rationalization! for! the! effect! of! the! R127W! mutation! is! less!
obvious,! but! it! is! clearly! destabilizing! in! the! context! of! the! dimer! and! favors! aggregation.!
Together,! these! results! suggest! that!mutations! in! sHsps! cause!amyloid! formation!and!gainBofB
function! toxicity;! these! results! are! supported! by! observations! from! cell! culture! and! patient!
samples!in!the!literature.!








































































It! is! important!to!also!discuss!evidence! linking!some!sHsps!mutations!to! lossBofBfunction.!First,!
though!most!sHsp!mutations!are!autosomal!dominant,!there!are!a!few!examples!of!autosomal!
recessive!disease! (L99M! in!Hsp27,!R54C! in!αABcrystallin)! (15,! 32).! Phenotypes! associated!with!
lossBofBfunction! diseases! are! typically! recessive,! suggesting! that! a! few! of! the! sHSP!mutations!
may!be! lossBofBfunction!disorders.!However,! the!majority!of!diseases! linked!to!sHsp!mutations!
are! dominantly! inherited.! Although! this! observation! could! support! a! gainBofBfunction!
phenotype,! it! is! also! consistent! with! haploinsufficiency! (32).! In! the! absence! of! a! molecular!
understanding! of! disease! etiology,! haploinsufficiency! is! indistinguishable! from! a! dominant!
! 58!
negative!phenotype.!But,! in!at! least! some!cases,! the!mutant! small!heat! shock!proteins! recruit!
and!coBaggregate!with!wildBtype!protein!(e.g.!R12C,!R21L,!R21W,!R49C,!R54C,!R116C,!and!R116H!
αABcrystallin! (22),! R120G! αBBcrystallin! (52),! and! P182L! Hsp27! (53)),! supporting! that! these!
mutations!are!dominant!negative!in!character.!Together,!these!studies!and!our!own!suggest!that!






ofBtoxic! function! aggregation.! Thus,! potential! treatments! for! these! sHspBassociated! diseases!
might!recover!the!stability!of! the!native! fold,!preventing!or!reversing!the!aggregation!process.!
Molecules!that!act!in!this!matter!are!known!as!pharmacological!chaperones,!because!they!work!









to! seven! bases! of! the!wild! type! sequence,! followed! by! the!mutated! codon,! and! eight! to! ten!
bases!of!the!wild!type!sequence.!Separate!reactions!were!initiated!with!the!forward!and!reverse!













cells! using! vortexing! and!pipetting.! Lysis! buffer! contained!20!mM!Tris,! 100!mM!NaCl,! 10!mM!
EDTA,!pH!8.0,! and!Roche!Complete!protease! inhibitor! (one!mini! tablet!per!100!mL!of!buffer).!
The!cells!were! lysed!by! two!passes!of!microfluidization!or!5!x!30!sec!of! sonication.!The! lysate!




allowed! to! stir! for!an!additional! ten!minutes!at! room! temperature.!The! resulting!mixture!was!
centrifuged!at!15,000!rpm!for!30!minutes,!the!supernatant!was!decanted,!and!an!additional!16.9!
(w/v)%!ammonium!sulfate!was!added!to!the!supernatant.!After!stirring!for!ten!minutes!at!room!
temperature,! the! resulting! mixture! was! again! centrifuged! at! 15,000! rpm! for! 30! minutes,!
resulting!in!precipitation!of!the!sHsp!protein!in!the!pellet.!Pellets!were!resuspended!into!MonoQ!
buffer!A!(20!mM!Tris,!pH!8.0)!and!dialyzed!into!4!L!of!buffer!A!overnight.!Protein!was!purified!by!
MonoQ! anion! exchange! chromatography! with! a! gradient! of! 0! to! 1! M! NaCl! over! 20! column!
volumes.! The!wildBtype! proteins! eluted! at! around! 150!mM!NaCl.! Fractions! containing! protein!














































































































































Proteins! were! applied! to! glowBdischarged! Formvar/carbon! 300Bmesh! copper! grids! (Electron!
Microscopy! Sciences)! and! stained!with! 2%!uranyl! formate.!Grids!were! visualized! on! a! Phillips!
CMB100!transmission!electron!microscope!at!an!accelerating!voltage!of!80!kV!with!magnification!
settings! ranging! from! 10,500–92,000x! (University! of! Michigan),! or! a! Fei! Technai! T20!
transmission!electron!microscope!at!an!accelerating!voltage!of!200!kV!with!magnification!from!


























and! spectral! widths! of! 1500! Hz! and! 9615! Hz! were! used! in! the! 1H! and! 15N! dimensions,!




















































































































































































































































































































































































































































NGterminal! hexahistidineGtagged! human! heat! shock! protein! 27! (His6Hsp27)! was! expressed! in!
Escherichia#coli!BL21!cells!using!the!pET!28b!vector.!Human,!wildGtype!αBGcrystallin!and!R120G!
αBGcrystallin! were! purified! in! E.# coli! Rosetta! cells! using! the! pMCSG7! vector.! Cultures! of!
transformed!cells!were!grown!to!an!optical!density!of!0.8!AU!at!600!nm!in!lysogeny!broth!media!
supplemented!with! 50! µg/mL! kanamycin! (pET! 28b)! or! ampicillin! (pMCSG7)! at! 37! °C.! Cultures!
were!induced!with!500!µM!IPTG!and!incubated!at!30!°C!for!8!to!16!hours.!After!incubation,!cells!
were!harvested!by!centrifugation!and!suspended!in!1/25!culture!volume!of!lysis!buffer!(20!mM!
Tris! pH! 8.0,! 100! mM! NaCl,! 6! M! urea,! 5! mM! βGmercaptoethanol,! 15! mM! imidazole).! The!
suspension! was! sonicated! on! ice! and! insoluble! material! removed! by! centrifugation.! The!
supernatant! was! loaded! onto! NiGNTA! resin! (10! mL/L! culture! volume)! and! washed! with! 10!
column! volumes!of!wash!buffer! (lysis! buffer! containing! 30!mM! imidazole).! The!proteins!were!
eluted! with! elution! buffer! (lysis! buffer! with! 150!mM! imidazole)! and! the! fractions! containing!
protein!were!pooled.!EDTA!was!added!to!5!mM,!and!the!unfolded!protein!was!concentrated!to!
~20! mg/mL! in! 10! kDa!MWCO! Amicon! centrifugal! filter! units.! The! proteins! were! refolded! by!
injecting! 1! mL! samples! of! concentrated! protein! onto! a! Superdex! 200! HR! 10/30! column!
equilibrated!with! refolding!buffer! (20!mM!sodium!phosphate,!pH!7.2,! 100!mM!NaCl)! at! room!
temperature.!The!refolded!protein!eluted!as!an!oligomer!(~24Gmer)!with!a!diameter!of!~165!Å,!
consistent!with!previous!literature!values!(22).!Protein!was!concentrated!to!~10!mg/mL!before!











library! was! composed! of! the! Spectrum! MS2000! and! NCC! collections! of! known! bioactives.!
Reactions! were! covered! with! silicon! oil! to! limit! evaporation.! The! plates! were! measured! in!





and! 0.71! and! the! CVs! were! 8%.! Treatments! that! reduced! the! apparent! Tm! by! 3! standard!
deviations! were! considered! actives.! For! αBGcrystallin! and! R120G! αBGcrystallin! differential!
scanning!fluorimetry!experiments,!a!similar!protocol!was!used,!but!the!buffer!contained!50!mM!




The!output!of! the!differential! scanning! fluorimetry!assay! is!a! set!of! fluorescence! intensities!at!




(version! 1.3.7):! a! sigmoidal! curve! fit! option!was! used!with! nonGconstant! yGupper! and! yGlower!
slopes! and! constant! dCp! =! 2500,! and! a!derivative! curve! fit!with! a! polynomial! degree! =! 2! and!
filter!points!=!3.!The!third!method!used!a!nonGlinear!least!squares!regression!to!fit!a!version!of!

















either! solvent! (1%! DMSO)! or! 100! µM! compound! 29,! then! incubated! for! 30! min! at! ambient!
temperature! before! applying! to! glowGdischarged! Formvar/carbon! 300Gmesh! copper! grids!
(Electron!Microscopy!Sciences)!and!staining!with!2%!uranyl!formate.!Grids!were!visualized!on!a!
Phillips! CMG100! transmission! electron! microscope! at! an! accelerating! voltage! of! 80! kV! with!
magnification! settings! ranging! from! 10500–92000×.! Shown! are! representative! images! and! at!
least! 12! random! fields! were! imaged! per! treatment! condition.! Scale! bars! represent! 1! µm.!
Disaggregation! experiments! were! performed! similarly.! R120G! αBGcrystallin! was! incubated! at!
ambient!temperature!for!30!minutes!and!then!a!sample!of!this!solution!was!visualized!by!EM!to!
ensure!fibril!formation.!The!aggregated!αBGcrystallin!was!treated!with!either!solvent!(1%!DMSO)!

















prior! to! beginning! an! experiment.! All! immobilization! steps! were! carried! out! onGline! on! a!
ForteBio!Octet! Red96! instrument!with! 1000! rpm! rotary! shaking! throughout.! Approximately! 7!





in! phosphate! buffer! at! 4! °C,! and! 50! µM! compound! 29! was! used! as! a! positive! control! at! the!




correct! for! drift! and! bulk! solvent! effects.! The! association! response! from! 290G300! sec! was!




! ! ! ! ! = !!!!!!!!! !!!!!!!! !and!!!! = ! !!!!!!!! .!!
!
3.8.7.!NMR!
15NGR120G! αBGcrystallin!aGcrystallin! domain! # (ACD)! was! expressed! and! purified! as! described!
previously! (23).! Resonances! in! R120GGACD! have! been! assigned! by! standard! NMR! techniques.!
HSQC! spectra! were! acquired! on! a! Bruker! Avance! III! 500!MHz! spectrometer! equipped! with! a!
triple! resonance,! zGaxis!gradient!probe.!10!mM!stock! solutions!of! compounds!29! and!16!were!
made!in!deuterated!DMSO.!Spectra!were!acquired!on!a!sample!containing!100!µM!R120GGACD!
and!either!1!mM!compound!29!or!compound!16!and!compared!to!a!reference!spectrum!of!15NG















αBGcrystallin! which! results! in! the! substitution! of! arginine! 120! with! glycine! (R120G)! were!
generated! as! described! previously! (21).! These!mice! are! in! the! C57BL/6J! background! (Jackson!
Laboratories,! Bar! Harbor! ME).! Mice! were! maintained! at! Washington! University! School! of!
Medicine!in!the!Division!of!Comparative!Medicine!by!trained!veterinary!staff.!All!protocols!and!
procedures! involving! mice! were! approved! by! the! Washington! University! Animal! Studies!












Mice! were! examined! by! slit! lamp! biomicroscopy! on! the! day! following! final! dosing.! Prior! to!
observation,! pupils! were! dilated! with! 1%! Topicamide! Ophthalmix! Solution,! USP! and! 10%!
Phenylephrine! Hydrochloride! Solution,! USP! in! a! 9:1! ratio.! The! slit! was! positioned! directly!
orthogonal! to! the!mouse! for! best! delineation! of! opacities! and! clear! areas! in! the! lens.! Videos!
from!each!eye!were! recorded!on!a!Sony!DCRGDVD403!3MP!DVD!Handycam!Camcorder!w/10x!
Optical!Zoom!with!Carl!Zeiss!VarioGSonnar!Super!Steady!Shot!(Sony,!Tokyo)!using!the!camcorder!





selected! images! were! analyzed! for! intensity! of! light! (as! gray! value! across! a! selected! cross!
section)! using! the! ImageJ! program! (http://rsb.info.gov/ij).! Plot! profiles! were! produced! along!





either! placed! in! a! unique!microcentrifuge! tube!with! 1!mL! PBS! and! 1:1000! protease! inhibitor!
cocktail!(Sigma,!St.!Louis!MO),!or!in!two!instances!were!pooled!with!lenses!from!other!mice.!The!
lenses! were! homogenized! using! disposable! grinders! before! centrifugation! for! one! hour! at!
10,000! rpm.! The! samples! were! kept! at! 4! °C! for! the! entire! process.! After! centrifugation,! the!
soluble! fraction! (supernatant)!was! collected! filtered! through!a!0.22!µm! filter,! transferred! to!a!
vial!and!analyzed!by!gel!permeation!chromatography!using!the!TDA305!detector!with!GPXMax!
injection! system! (Malvern,! Worcestershire,! UK).! The! system! provided! refractive! index,!
ultraviolet! absorbance! at! 280! nm,! viscosity,! and! right! and! lowGangleGlightGscattering! readings!
after!each!sample!passed!through!a!P3000!and!P2500!column!(Malvern).!PBS!was!used!as!the!
mobile!phase!and!the!system!was!calibrated!with!bovine!serum!albumin!(Sigma)!as!a!standard.!
The! results! were! displayed! using! OmniSec! 4.7! software! (Malvern).! Gel! permeation!
chromatography!data!were!analyzed!using!SAS!version!9.3!(SAS!Institute;!Cary,!NC).!The!effect!of!
compound!29!on!the!level!of!soluble!crystallins!was!expressed!as!the!percent!difference!in!area!
between! the! treated!and!untreated! fellow!eyes.! To! control! for!differences! in! assay! sensitivity!
among!animals,! the!area!under! the!curve! in! the! treated!eye!was!compared!to! the!area! in! the!







Human! lenses! (HL)! used! in! this! study! were! obtained! from! unidentified! patients! (70G80! years!





as!mixed! cortical! and!nuclear! 3G4! l.! The!material! had!been! classified! as!nonGhuman!discarded!
material.! HL2! and! HL3! were! obtained! from! a! deceased! patient.! Each! lens! was! cut! into! four!
nearly! equal! parts! and! placed! in! individual! tubes.! To! each! tube!was! added! 50! µL! solution! of!
vehicle!(40%!cyclodextrin!in!PBS!containing!1:1000!protease!inhibitor!cocktail)!or!compound!29!
(1!mM)!in!vehicle!which!covered!the!lens!tissue!completely.!Lens!tissue!was!incubated!in!these!
solutions! for! 6! days! in! the! dark! at! room! temperature.! On! the! last! day,! the! tissue! was!
homogenized!after!addition!of!200!µL!PBS.!An!aliquot!(40!µL)!was!removed!and!centrifuged!for!










performed! the! original! ThermoFluor! screen! against! Hsp27! and! developed! the! data! analysis!
method.! Andrea! Thompson! visualized! αBGcrystallin! amyloid! by! electron! microscopy.! The!
ThermoFluor! instrument! was! a! generous! gift! from! Johnson! &! Johnson,! and! the! original! 32G
























































































In! the! post,genomic! era,! potential! therapeutic! targets! accumulate! genetic! evidence! that!
validates! their! utility! in!modifying! the! course! of! disease.! Genetically! validated! targets! do! not!
necessarily! possess! small! molecule! modulators,! known! ligand! binding! sites,! or! even! enzyme!
activity.!Consequently,!some!non,enzymatic,!non,receptor!targets!such!as!the!small!heat!shock!
protein! Hsp27! require! de# novo! chemical! validation.! While! Hsp27! is! known! to! have! disease,
modifying! properties,! does! it! possess! ‘druggable’! binding! sites?! Can! the! disease,modifying!
activity!of!Hsp27!be!tuned!using!small!molecules?!Because!of!the!complexity!of!this!target,!we!





and! a! parallel! peptide! synthesis! effort.! The! fragment! based! screen! relied! on! ~1000! unbiased!
chemical! fragments,! while! the! peptide! approach! was! based! on! a! recently! identified! protein,
protein! interaction!motif! in! Hsp27.! Together,! these! approaches! yielded! three! cryptic! binding!
sites!on!Hsp27.!Each!of! these!sites!was!subject! to!medicinal!chemistry!efforts,!and!the!results!
suggested!that!some!of!these!sites!are!more!amenable!to!tight!binding!than!others.!Finally,!one!
site! appears! to! be! functionally! important! in! maintaining! the! solubility! of! sHSPs.! From! these!
efforts,!we!have!revealed!previously!uncharacterized!ligand,binding!sites!on!Hsp27!and!gained!
insight! into! the! allostery! and! function! of! this! chaperone.! These! efforts! also! provide! an!





Hsp27! belongs! to! the! superfamily! of! molecular! chaperones! responsible! for! maintaining!
proteostasis!under! stress! conditions.!Unlike! the!well! known!Hsp70!and!Hsp90! families,!Hsp27!
has! no! intrinsic! ATP! hydrolyzing! activity.! Rather,! it! is! known! to! bind! its! protein! clients,! and!
sequester! them! from! self,association! (aggregation)! or! degradation.! Once! the! stress! abates,!
Hsp27! can! release! its! clients! for! active! refolding!by!other! chaperones.! Structurally,! small! heat!
shock! proteins! consist! of! a! highly! conserved! core! immunoglobulin! fold! called! the! α,crystallin!
domain,! flanked! by! less! conserved! and! less! ordered! N,! and! C,terminal! extensions! (1,! 2).! The!
core!α,crystallin!domain!forms!a!dimer!at!an!antiparallel!beta!strand!interface,!and!contacts!in!
the!N,!and!C,terminal!extensions!mediate!higher!ordered!oligomerization.!The!ultrastructure!of!
Hsp27! is! regulated! by! heat! shock,! oxidative! stress,! and! phosphorylation! on!N,terminal! serine!
residues!(3,!4).!Quaternary!structure!dynamics!control!the!bind,and,release!properties!of!small!




a! small!molecule! to! regulate!Hsp27! structure! and! function?!We! sought! to! chemically! validate!
Hsp27!as!a! ‘druggable’!protein!and!to!make!early!steps! towards! the!development!of!chemical!
probes!of!Hsp27!biology.!!
4.3.(Atomic(level(structure(of(core(αEcrystallin(domain(of(Hsp27(





of! two! β,strands! that! associate! in! an! antiparallel! fashion.! Hsp27! has! a! single! cysteine! that! is!
positioned!in!the!dimer!interface,!and!in!the!NMR!structure!the!cysteine!from!one!protomer!is!
directly!across! from!the!cysteine! from!the!other!protomer! in! the!so,called!antiparallel! II! (APII)!
register!of!the!dimer!interface.!!
! 87!
The! dimeric! core! domain! of! sHsps! is! known! to! exhibit! chaperone! activity! (1)! and! is! also! the!




Figure! 4.1.! A.! Solution! NMR! structure! of! Hsp27! αB,crystallin! domain,! residues! 79,176.! B.! Features! of! the! primary!




A! first! step! in! identifying! ligands! is! to! identify! potential! small! molecule! binding! sites! on! the!
target’s!surface.!We!chose!to!focus!on!the!Hsp27!core!domain,!since!we!had!access!to!a!high,
resolution!structure!of!this!construct,!and!because!we!hypothesized!that!the!dimer!would!be!a!
physiologically! relevant! target! given! its! critical! role! in! the! substructure! of! Hsp27! oligomers!






the! solvent! probes! cluster! at! regions! on! the! surface! of! the! protein! where! each! solvent! can!
outcompete! water,! and! these! locations! represent! potential! ligand! binding! pockets! (9).! We!
wanted!to!test!the!predictive!power!of!the!MixMD!technique!while!using!it!to!identify!potential!
ligandable! pockets! in!Hsp27’s! core! domain.! In! this! case,! three! probes!were! used:! acetonitrile!
(hydrophobic),!pyrimidine!(aromatic),!and!isopropanol!(hydrogen!bond!donating!and!accepting).!
This! system!was! then!minimized! in!a!molecular!dynamics! simulation! incorporating! full!protein!
flexibility.!We!interpreted!the!regions!that!were!highly!occupied!by!all!three!probes!after!20!ns!




β4! and! β8! strands.! The! third! site! occupies! a! concave! pocket! on! the! bottom! of! the! dimer!
interface.!These!sites!will!be!referred!to!as!Site!1,!Site!2,!and!Site!3!in!the!following!discussion.!
!
Figure! 4.2.! Surface! rendering! of! NMR! structure! of! Hsp27! αB,crystallin! domain,! showing! three! regions!where! each!




4.5.(Validation(of(MixMD( result( through(equivalent(NMR(experiments( and( comparison(with(
chemical(shift(perturbations(
Using!the!construct!of!Hsp27’s!core!domain!that!is!well!behaved!in!solution!NMR!experiments,!
the! experimental! equivalent! of! the!MixMD! simulation! was! carried! out.! Solvents! (pyrimidine,!









Figure! 4.3.! Cartoon! rendering! of! NMR! structure! of! Hsp27! αB,crystallin! domain,! showing! MixMD! solvent! probe!
occupancy!maps!and!backbone!chemical! shift!perturbations! for!solvent!mapping!NMR!experiment.!Backbone!shifts!






Site! 1! is! formed! by! the! β6/7! strands! of! two! protomers.! This! region! is! interesting! because! it!
comprises! the! monomer,monomer! interactions! that! stabilize! the! core! Hsp27! dimer.! Thus,!
interactions! in! this! region!might!be!expected! to!affect!chaperone! function.!Additional! support!
for! the! presence! of! a! ligand,binding! pocket! at! Site! 1! can! be! gleaned! from! published! crystal!
structures!of!the!core!domains!of!αB,crystallin!and!Hsp20.!In!crystal!structures!of!αB,crystallin,!
the!crystallization!additives!methylpentanediol!and!sulfate!populate!this!site,!suggesting!that!it!
sometimes! binds! small! molecules! (10).! In! addition,! a! rat! Hsp20! αB,crystallin! core! domain!
structure!shows!that!C,terminal!peptides!from!adjacent!dimers!in!the!crystal!lattice!bind!in!the!
groove!of!Site!1!(11).!While!affinity!for!solvent,like!probes!is!suggestive!of!a!ligand,binding!site,!
we!wanted!to! take!the!next!step!and! identify!drug,like!small!molecules!engaging! this!site.!For!
Site! 1,! we! chose! to! take! a! high,throughput! screening! approach,! beginning! with! differential!
scanning!fluorimetry.!
!
Differential! scanning! fluorimetry! (DSF)!was!discussed! in!Chapter!1! (1.9)! and!applied! to!R120G!
αB,crystallin!in!Chapter!3.!From!the!same!pilot!screen,!we!identified!a!‘hit’!that!altered!melting!
temperature! of! the! full,length! Hsp27! by! ,1.6°C! in! a! dose,dependent! fashion! (Figure! 4.4).!



















cysteine,!which! is! located!at! the!dimer! interface,! in! the! floor!of! Site!1.! To!probe!whether! the!
affinity! was! purely! a! result! of! the! reactive! thiol,! or! whether! the! molecule! also! had! other!
physicochemical! interactions! and! noncovalent! affinity! with! the! pocket,! we! mutated! the!
endogenous!cysteine!to!alanine!and!repeated!the!HSQC!binding!experiment.!The!residues!in!the!
binding!pocket!still!show!chemical!shift!perturbations!at!high!concentrations!of!captopril!(Figure!
4.5),! though! captopril’s! ability! to! form!a!mixed!disulfide!with! the!protein! is! eliminated!by! the!








The! role!of! the! cysteine! in!Hsp27!biology! is! not!well! understood.!No!other!human! small! heat!
shock!protein! has! a! cysteine!within! the!dimer! interface.!Disulfide,bound!dimers! of!Hsp27! are!
known!to!be!present!in!cells,!and!the!proportion!of!covalent!dimer!increases!upon!treatment!of!
cells! with! oxidants! including! hydrogen! peroxide,! diamide,! and! arsenite! (12,! 13).! The! inter,
protomer!disulfide!bond! locks! the!dimer! in! a! single! registration!of! the!β,strand! interface;! the!
cross,dimer! distance! between! the! cysteine! Cα! atoms! is! 5! Å,! whereas! in! the! other! possible!
registers! of! the! dimer! interface! it! is! ~8.8! Å! (2)! which! precludes! disulfide! formation! (14).!
Interestingly,! disulfides! formed! between! residues! on! adjacent! β,strands! are! rare,! and! cross,
strand! disulfides! formed! between! hydrogen,bonded! residues! on! adjacent! β,strands! are! even!
more! unusual! (15).! A! 2011! study! found! 2576! examples! of! cross,strand! disulfide! bonds! in! the!
PDB,! only! six! of! which! are! found! between! hydrogen,bonded! pairs.! Such! disulfides! are! highly!
strained!and!usually!act!as!redox!switches!(16,!17).!Given!the!known!roles!of!Hsp27!in!protecting!
against! oxidative! stress! (18,! 19)! and! the! location! of! the! strained! cross,strand! disulfide! at! the!
critical!dimer!interface,! it!seems!likely!that!the!disulfide!acts!as!a!redox!sensor.!Several!studies!
have!examined!the!role!of!the!cysteine!in!human!Hsp27!or!its!murine!homologue,!Hsp25!(12,!13,!
20,24).! In! cells,! mutation! of! the! cysteine! residue! to! alanine! was! reported! to! reduce! Hsp25’s!
oligomeric! size!and!abolish! its! chaperone!activity! towards! luciferase! in! cells! (20).!Additionally,!
the! cysteine! to! alanine! mutation! slightly! reduced! Hsp25’s! ability! to! protect! cells! from!
staurosporine,induced!apoptosis!(20).!However,!a!second!group!observed!no!significant!changes!
to! the! chaperone! function,! oligomeric! size,! or! secondary! structure! of! Hsp25! in# vitro! (13),!







in!Chapter!1! (1.8)!as!a!site,directed!screening!method,! in!which!an! introduced!or!endogenous!
cysteine!is!used!to!‘tether’!molecules!from!a!screening!library!via!mixed!disulfide!adducts!with!
the! protein! target.! An! in,house! library! of! 1280! small! molecule! fragments! containing! reactive!
thiols! was! screened! for! binding! to! Hsp27’s! core! domain! in! the! presence! of! 100! μM! β,
mercaptoethanol.! The!hit! rate! for! the!primary! screen!was!nearly! 5%,!using! a! typical! cutoff! of!
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50%! adduct! formation! to! differentiate! hits.! This! suggests! that! Site! 1! is! amenable! to! small!
molecule!binding,!as!predicted!by!the!MixMD!simulation.!The!potential!for!optimal!non,covalent!
affinity! at! this! pocket! remains! to! be! determined,! as! does! the! functional! consequence! of!
irreversibly! or! reversibly! engaging! this! site.! Another! graduate! student! has! been! leading! the!





(Figure! 4.1).! Interestingly,! this! site! is! known! to! participate! in! homomeric! and! heteromeric!
protein,protein! interactions.! This! region!binds! to! an! IXI! palindromic!motif,!which! is! located! in!
the! C,terminal! extension! of! Hsp27.! The! interaction! of! the! IXI! motif! with! Site! 2! in! the! core!
domain! stabilizes!Hsp27!oligomers,! likely!mediating! inter,monomer! contacts! (1).! Several!NMR!
and!crystallography!studies!of!αB,crystallin!and!Hsp27!have!documented!IXI!peptide!binding!to!
this!groove!(1,!25,!26).!Secondly,!the!β4,β8!groove!is!known!to!mediate!the!interaction!of!sHSPs!
with! BAG3.! BAG3! is! a! nucleotide! exchange! factor! for! heat! shock! protein! 70! (Hsp70)! and! is!
thought! to! serve! as! a! scaffolding! protein! that! links! Hsp70! with! the! sHSPs.! The! sHsps! Hsp20!
(HspB6),!Hsp22!(HspB8),!and!αB,crystallin!have!each!been!reported!to! interact!with!BAG3!(27,!
28).! Moreover,! the! Landry! group! has! carried! out! extensive! mutagenesis! and!
immunoprecipitation!studies!to!identify!the!regions!in!each!binding!partner!that!are!required!for!
the! interaction! (27).! In! the! case! of! Hsp20! and! Hsp22,! mutation! of! several! conserved!
hydrophobic!residues!in!the!β4!and!β8!abrogated!the!binding!interaction!(27).!The!same!group!
used! deletions! and!mutagenesis! to! identify! the! regions! in! BAG3! that! are! responsible! for! the!
interaction,!and!found!that!two!IPV!motifs!within!BAG3!are!necessary!for!the!binding!interaction!
(27).! These! IPV! motifs! are! very! similar! to! the! C,terminal! Hsp27! IXI! motifs! (see! alignment! in!
Figure!4.7).!
!
To! gain!more! insight! into! Site! 2,! we! used! NMR! to! show! that! full! length! BAG3! and! synthetic!
peptides!containing!the! IPV! interaction!motifs!bind!to!the!Hsp27!core!domain! in!the!expected!
β4/β8!groove!(Figure!4.6).!By!isothermal!titration!calorimetry,!full!length!BAG3!binds!to!Hsp27c!













Because! Site! 2! is! involved! in! important! protein,protein! interactions,! we! wondered! whether!
ligands! for! this! region!might!alter! the!oligomerization!of!Hsp27.!Specifically,!we!reasoned!that!
peptide!binding!in!Site!2!should!compete!with!the!ability!of!the!Hsp27!IPV!motif!to!bridge!across!
dimers,!weakening! the! oligomer! structure.!When! 100! μM!of! full,length!Hsp27!was! incubated!
with!1!mM!or!2!mM!of!the!8,mer!peptide!H2NIPIPVLHECOOH!from!BAG3,!a!slight!reduction!in!the!
size!of!the!oligomer!was!observed!by!size!exclusion!chromatography!coupled!to!multi,angle!light!
scattering! (SEC,MALS)! (Figure! 4.7).! Though! the! change! was! relatively! small,! it! was! dose,
dependent! and! reproducible,! and! each! value! in! the! table! represents! the! average! of! two!
experiments.!Because!the!binding!of! IPIPVLHE! is! fairly!weak!(KD!=!8!μM),! it! is!difficult!to!reach!
concentrations!that!can!compete!with!the!self,interaction!with!the!IPV!motif.!Consequently,!the!
binding! sites! are! not! likely! to! be! saturated! in! this! experiment.!However,! ongoing!work! in! the!
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in!αB,crystallin!with! the!highest!amyloid,forming!propensity! (29).!This!11,mer!peptide! formed!
cytotoxic!amyloid!oligomers!with!six!peptide!units!per!oligomer,!and!the!crystal!structure!of!the!
resulting!oligomer!was!solved!to!reveal!a!hexameric!β,barrel!with!each!β,strand!antiparallel!to!
its! neighbors! (29).! Thus,! we! hypothesized! that! engaging! Site! 2! with! a! peptide! may! limit! re,
arrangement! to! the! amyloid! conformation.! Consistent! with! this! idea,! peptides! from! BAG3!
suppressed!aggregation!of!R140G!Hsp27!as!measured!by!light!scattering!(Figure!4.8)!by!delaying!
its!lag!time.!The!peptide!consisting!of!BAG3!residues!94,111!completely!suppressed!aggregation!









When! the! peptides!were! tested! against! the! even!more! aggregation,prone!R120G!mutant!αB,
crystallin,! they! were! effective! at! suppressing! aggregation! but! exhibited! different! inhibition!
behavior!in!this!assay!(Figure!4.9).!The!BAG3!peptides!primarily!slowed!the!rate!of!aggregation!
of!R120G!αB,crystallin,!had!less!of!an!effect!on!its! lag!time,!and!required!much!higher!peptide!




Figure! 4.9.! Peptides! from! BAG3! suppress! the! aggregation! of! R120G! αB,crystallin! as! measured! by! light! scattering.!
BAG3!94,111!can!completely!suppress!aggregation!at!the!highest!concentration!tested!while!BAG3!206,213!is!slightly!
less! effective.! The! concentration! of! R120G! αB,crystallin! is! 43! μM! (in! monomer),! so! the! effective! peptide!
concentrations!are!in!large!excess.!!
!
These! results! suggest! that! the! peptides! bind! to! the! native! fold! of! the! protein! and! prevent!
nucleation!of!aggregation! (R140G!Hsp27)!or!propagation!of!aggregation! (R120G!αB,crystallin).!
Thus,! engaging! Site! 2! appears! promising! as! a! potential! means! of! inhibition! of! mutant! sHsp!
amyloid!formation.!
!










































chose! to! apply! fragment,based! drug! design! by! NMR.! This!method! for! the! label,free,! affinity,
based!selection!of!ligands!was!introduced!in!Chapter!1.8.!In!this!approach,!low!molecular!weight!
fragments!are!expected!to!bind!weakly,!but!with!high!atom!efficiency,!enabling!straightforward!
optimization!by!growing!or!combining! fragments! into!higher,affinity! ligands.!The!advantage!of!
fragment,based!drug!design!by!NMR!is!that!the!binding!sites!of!the!fragments!are!identified!as!
part! of! the! routine! screening! process.!We! chose! to! use! the! Klevit! laboratory’s! uniformly! 15N,
labeled!Hsp27! core!domain!as! a! target! for! a!protein,observed!HSQC! screen!of! the!Maybridge!
RO3! library! of! ~1,000! fragment! molecules,! carried! out! in! collaboration! with! the! Cierpicki!
laboratory.! Because! protein,observed! HSQC! screens! are! information! rich! but! relatively! low!
throughput,! we!multiplexed! the! fragments! in! groups! of! 20! fragments! per! HSQC! experiment,!





for! a! library! of! this! size,! correlated! with! the! success! of! subsequent! medicinal! chemistry!
campaigns! to! access! optimized! hits! with! high! affinity! (<300! nM)! (30).! While! we! only!
deconvoluted! six! of! the! thirty,three!mixtures! of! compounds! that! produced! hits,!we! obtained!

















and! isolated! as! 78%! E,olefin,! the! molecule! that! was! represented! in! the! Maybridge! library!
product! information.! This! molecule! did! not! bind! to! Hsp27c! by! HSQC! NMR! under! conditions!
similar! to! the! screening! conditions.!However,!we!noticed!upon! inspection!of! the!proton!NMR!
spectrum!of!the!original!screening!sample!that!the!3JHH!coupling!constant!for!the!alkenyl!protons!
was!characteristic!of!the!Z,olefin!(Figure!4.12),!and!not!the!E,olefin!as!drawn.!The!Z,olefin!was!


















denote! compounds! that!were! purchased! from! commercial! libraries.! The! synthetic! procedures!

















material! 5! bound! more! tightly,! giving! saturable! binding! curves! in! the! HSQC! titration! and! an!
apparent!affinity!of!177!±!16!μM.!Nitro!substitution!at!the!5,position! instead!of!the!3,position!
resulted! in!a! further! improvement! in!affinity! to!63!±!3!μM!(6).!Removal!of!either! the!pyridine!
nitrogen! or! 2,fluoro! substituent! individually! had! little! effect! on! affinity! (compounds! 7! and! 8,!
respectively).! Ligand! efficiency! is! a!metric! often! used! in! fragment! optimization! efforts! that! is!
intended!to!control!for!the!effect!of!molecular!weight!or!number!of!heavy!atoms!in!affinity!(31).!
Ligand!efficiency!was!calculated!using!the!formula!–ΔG!(kcal/mol)/#heavy!atoms,!where!ΔG!was!
calculated!at!303!K! (the! temperature!at!which!all!NMR!experiments!were! carried!out)! and!all!
non,hydrogen!atoms!were!counted!as!heavy!atoms!(31).!Interestingly,!2,4,difluoro!substitution!
on!the!right,hand!ring!was!found!to!be!optimal!when!the!left,hand!ring!bore!nitro!substituents!
at! the! 2! and! 4! positions! (compare! 11( to! 9( and! 10).! The! position! of! the! nitro! groups! was!
important,! as! seen! from! a! comparison! of! compounds! 11! and! 12.! This! precludes! a! purely!




the! fluorines!with! other! halogens,! a! trifluoromethyl! group,!methyl! groups,! an! aldehyde,! or! a!
carboxylic!acid!is!poorly!tolerated!(compounds!22,!26E30).!Interestingly,!the!ether!oxygen!can!be!
replaced! by! sulfur! with! a! slight! improvement! in! affinity! (41),! but! not! with! a! nitrogen! atom!
(compounds!40! and( 42).! The!nitrogen! substitution!would!be! expected! to! restrict! the!possible!
orientations! of! the! two! planar! rings! relative! to! one! another,! which! may! preclude! binding.!









Since! Site! 1! and! Site! 2! are! related! by! their! locations! on! either! side! of! the! β,sheet! dimer!
interface,! and! since! the! HSQC! experiment! reports! on! the! electronic! environment! of! the!
backbone!amides,!the!observed!chemical!shift!perturbations!are!ambiguous!as!to!which!binding!
site! is! engaged! (Figure! 4.13).! To! distinguish! Site! 1! and! Site! 3! and! identify!which! residues! are!
engaged!with!ligand!binding,!we!systematically!mutated!each!of!the!side!chains!involved!in!Site!
1! and! Site! 3! and! tested! the! optimized! compound! 11! (1,(2,4,difluorophenoxy),2,4,
dinitrobenzene)! for! binding! to! each!mutant! in! the! same!HSQC!platform! (Figure! 4.14).! Several!
mutations! in! Site! 3! severely! reduced! (e.g.! H46A)! or! completely! abolished! binding! (e.g.! R58A,!
F60A,!and!R62A).!Conversely,!mutations!in!Site!1!had!only!minor!effects!on!the!apparent!binding!
affinity.!These!studies!confirmed!that! the!diaryl!ether!scaffold!engages!Site!3,! likely!via!critical!
contacts! with! residues! H46,! R58,! F60,! and! R62.! These! results! validate! Site! 3! as! a! bona# fide!
ligand,binding!pocket.!!
! !




















expand! upon! this! suite! of! chemical! ligands,! which! represent! valuable! starting! points! for! the!





Proteins! were! purified! as! described! in! Chapter! 2;! see! 2.13.2! for! details.! Hsp27! core! domain!






HSQC!spectra!were!acquired!at!30! °C!on!a!600!MHz!Bruker!Avance! III! spectrometer!equipped!












Oligomeric! samples!were! resolved!by! analytical! size! exclusion! chromatography!with! a! Shodex!
803!column!on!an!Ettan!LC!(GE!Healthcare).!Molecular!weights!were!determined!by!multiangle!
laser! light! scattering! using! an! in,line! DAWN! HELEOS! detector! and! an! Optilab! rEX! differential!

























































































































































































































































































































































































































































































































































The! immediate! goals! for! further! development! of! ligand! development! for! αB7crystallin! are!
translational! in! nature,! while! the! immediate! next! steps! for! Hsp27! ligands! are! oriented!more!
towards! chemical! biology.! The! pharmacological! chaperones! for! R120G!αB7crystallin! that!were!
discussed! in! Chapter! 3! will! be! developed! as! potential! therapeutics! for! the! treatment! of!
cataracts;!first,!their!safety!and!efficacy!will!be!evaluated!in!animal!models!of!disease,!and!the!
pharmacokinetics! of! the! lead! molecules! in! the! lens! will! be! systematically! studied.! Important!
outstanding!questions!will!be!addressed.!First,!the!duration!of!therapeutic!effect!will!be!studied:!
once! cataract! is! reversed,! does! protein! aggregation! recur?! How! long! after! the! molecule! is!
excreted!from!the!lens!tissue!does!this!happen?!Second,!the!mechanism!of!oxysterol!action!will!
be! further! investigated:!what!quaternary! forms!of!αB7crystallin!are! favored!by! small!molecule!
treatment! in! vivo?! Does! oxysterol! binding! cause! the! protein! to! revert! back! to! native7like!
oligomers?! Can! we! observe! and! measure! the! recovery! of! αB7crystallin! chaperone! function!
towards!other!lens!structural!proteins!in!vitro?!Additionally,!second7generation!molecules!based!




permeable! probes! for! Hsp27! biology! targeting! each! binding! site! described! in! Chapter! 4.! Co7
crystal! structures! of! each! molecule! with! the! Hsp27! α7crystallin! domain! are! expected! to!
significantly! facilitate! these! efforts.! Another! graduate! student! in! the! Gestwicki! laboratory,!
Rebecca! Freilich,! is! already! working! towards! these! goals.! Tight7binding! scaffolds! that! engage!
each! site! should! inform!our!understanding!of! allostery!within! the!Hsp27! structure.! Site!2,! the!
site! of! the! endogenous! protein7protein! interaction,! appears! to! be! promising! as! a!












As! discussed! in! Chapter! 2,! aggregation! of! these! proteins! appears! to! be! an! important!
contributing!factor!to!the!pathology!associated!with!many!of!the!disease7causing!mutations.!But!
what!regulates!the!function!of!the!native!conformations!of!the!proteins?!Do!discrete!structures!




conformation! of! a! protein?! While! the! ligands! identified! in! this! body! of! work! appear! to!
differentiate! between! native! and! non7native! conformations,! can! tools! be! identified! which!
stabilize!one!native!conformation!over!another!native!conformation?!Analogues!for!this!type!of!
PC! exist! in! other! areas! of! biology.! For! example,! recent!work! identified! a! peptidic! inhibitor! of!
caspase76! that! stabilizes! an! inactive,! tetrameric! conformation! of! the! protein! (1).! Even! some!
ligands! from!classic!pharmacology!might,! in! fact,!act!via!a!PC!mechanism;! for!example,! recent!
studies! suggest! that! nicotine! exerts! its! effects! by! thermodynamically! stabilizing! a! single!
conformation!of!the!acetylcholine!receptor!(2,!3).!However,!our!emerging!understanding!of!sHsp!
structure!is!one!of!a!dynamic,!fluid!system!made!up!of!a!number!of!low7affinity!interactions,!and!
there! is! a! dearth! of! structural! knowledge! of! the! full7length! proteins.! It! remains! to! be! seen! if!




using! a! technique! that! directly! reports! on! the! native,! quaternary! structure! of! an! sHsp.! For!




ray! scattering,! and! electron! microscopy! would! be! useful! for! the! lower7throughput!
characterization! of! conformations! favored! by! hits! identified! in! such! platforms! and! their!
subsequent! optimization.! If! a! set! of! small! molecules! favoring! distinct! native7like! quaternary!
conformations! could! be! identified,! such! a! toolkit! would! be! fascinating! to! study! in! a! cellular!
context.! The!ultimate! goal! of! this! discovery! effort!would!be! to! identify! a!molecule! that! could!
activate!the!protein!in!a!disease!model!to!phenocopy!genetic!modulation!of!protein!expression!
level.!As!discussed! in!Chapter!1,!a! small!molecule! that! could! increase! the!concentration!of!an!
‘active’!chaperone!conformation!of!an!sHsp!and!phenocopy!overexpression!would!be!expected!









An!even! smaller! subset!may!have!proof7of7concept! in!modifying! the!progression!of! disease! in!
animal!models.!Non7canonical!targets!that!possess!two!or!three!of!these!characteristics!may!be!
most!promising!for!discovery!efforts.!In!addition!to!providing!support!for!the!disease7modifying!
capacity! of! the! target,! point! mutations! that! modify! the! target’s! activity! provide! a! starting!
framework!for!differentiating!healthy!and!pathological!characteristics!of!the!protein!of!interest,!
and!suggest!an!avenue!towards!the!identification!of!activity7modifying!ligands.!Small!heat!shock!
proteins,! especially!Hsp27!and!αB7crystallin,! have!all! three!of! these! types!of! genetic! evidence!
supporting!their!promise!as!therapeutic!targets.!
!
In! an! ideal! situation,! parallel! development! paths! would! be! taken.! One! workflow! would! be!
focused!on!understanding!the!effects!of!the!mutations!on!relevant!protein7protein!interactions,!
substrate!or!ligand!interactions,!enzyme!activity!if!the!target!has!such,!subcellular!trafficking!or!
localization,! protein! folding! and! stability,! tertiary! and! quaternary! structure,! and! post7
translational!modifications.! One! of! the! unanticipated! difficulties! surrounding! this! project! and!
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discovery!against!non7enzymes!in!general!is!the!lack!of!appropriate!secondary!follow7up!assays.!
Thus,!concurrent!with!discovery!efforts,! the!development!of!bioassays! that! report!on!relevant!
biological!activity!is!essential.!A!parallel!workflow!might!resemble!the!work!undertaken!against!
Hsp27!in!Chapter!4:!first,!structurally!characterize!the!target,!in!whole!or!in!part,!and!then!use!a!
validated! computational! technique! (like! MixMD)! or! experimental! techniques! (like! solvent!
mapping!by!NMR!or!fragment7based!screening)!to!identify!ligandable!binding!sites!in!the!target.!
Then,! suitable! screening! techniques! can! be! applied! to! generate! first7in7class! ligands! for! any!
identified! pockets.! Once! ligands! are! identified,! they!may! then! be! characterized! for! activity! in!







A! 2011! analysis! suggested! that! only! 435! unique! biomolecules! in! the! human! genome! are! the!
targets!of! therapeutic!drugs! (4).!The!same!study!found!that! in!an!average!year,!only! four!new!































towards!expanding! the!definition!of! ‘druggable,’!and!develop!approaches! that!are! tailored! for!
targets!other!than!enzymes!and!receptors.!As!discussed!in!Chapter!1,!this!means!expanding!our!
armamentarium!of!chemical!libraries!and!screening!techniques.!Lastly,!the!broader!utility!of!the!











molecules! that! distinguish! between! native! quaternary! or! tertiary! structures.!We! learned! that!
many!of! the!pathological!mutations! in! sHsps!cause!gain!of! toxic! function!aggregation,!and!we!
identified!molecules! that! bind! to! native! conformations! to! disfavor! (and! even! to! reverse)! the!
aggregation!of! these!proteins.!Our!hypotheses!have!evolved!and!become!better! suited! to! the!
study!of! sHsps,!given!an!understanding!of! their!complexities!and!a!practical!knowledge!of! the!
assays! that! are! amenable! for! their! study.! Pharmacological! chaperones! that! discriminate!




In! a! broader! sense,! I! want! to! highlight! a! fundamental! dilemma! associated! with! categorizing!
‘druggable’! targets! and! ‘drug7like’! molecules! on! the! basis! of! past! success! stories! (5).! If! we!
categorize! ‘druggable’! targets! as! only! those! that! resemble! successfully! drugged! targets,! and!
‘drug7like’!small!molecules!as!only!those!that!resemble!current!FDA7approved!compounds,!then!
we!limit!innovation!and!exclude!the!possibility!that!either!target!space!or!drug!space!might!be!
expanded!by!new! technology.! In!other!words,!until!we! try!–!and! fail! –! it! is!not! clear! that!any!
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target! is! ‘undruggable’! and,! even! then,! it! is! only! ‘undruggable’! under! the! current! paradigm.!
Accordingly,! we! have! focused! this! thesis! on! exploring! high7throughput!methods! for! selecting!
ligands! with! affinity! for! non7canonical! targets.! These! methods! have! been! used! against! small!
heat!shock!proteins,!targets!that!lack!enzymatic!activity,!structural!information,!existing!ligands,!
or! known! ligand!binding! sites.! Because!of! these! characteristics,! small! heat! shock!proteins! are!
challenging!examples!of! non7canonical! targets.!However,! using!multiple!methods,! I! show! that!
they! are! amenable! to! drug! discovery.! Combined! with! efforts! to! expand! chemical! space! and!
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HSF1! is! a! compelling! therapeutic! target! for! diseases! in! which! proteostasis! is! dysregulated,!
including! neurodegenerative! diseases! (1).! Like! sHsps,! HSF1! is! a! noncanonical! target! for! drug!
discovery:! it! lacks!enzymatic! activity,! known! small!molecule! ligands!and!known! ligand!binding!









Chaperone! proteins! are! upregulated! in! response! to! a! number! of! cellular! stresses,! including!
elevated!temperature,!oxidative!stress,!exposure!to!heavy!metals,!inflammation,!and!infection.!
Molecular! chaperones! operate! as! an! interconnected! network! to!maintain! proteostasis! under!
such!stresses.!Heat!shock!transcription!factor!1!(HSF1)!coordinates!and!controls!the!cellular!heat!
shock! response! by! mediating! the! expression! of! each! stressMinducible! chaperone! (2).! Its!
transcriptional!activity! is!tightly!regulated!by!a!number!of!factors,! including!complexation!with!
chaperone! proteins,! quaternary! structure,! subcellular! localization,! and! postMtranslational!








proteotoxic! stress! conditions,! increased! levels! of! unfolded! proteins! compete! with! HSF1! for!
binding!to!the!chaperone!components!of!the!multiprotein!complex,!freeing!HSF1!from!Hsp90!(1,!
4).!HSF1!can!then!homotrimerize!and!translocate! to! the!nucleus.!Trimerization! is!mediated!by!
three! leucine!zipper!domains!near!the!NMterminus!of!the!protein!and!enforced!by!oxidation!of!
disulfide! bonds! and! phosphorylation! of! serine! residues! (5,! 6).! Inside! the! nucleus,! the! HSF1!
trimer!can!bind!to!cisMacting!heat!shock!elements!in!the!promoter!regions!of!heat!shock!genes,!
consisting!of!repeating!nGAAn!sequences.!After!binding!to!DNA,!HSF1!releases!Hsp70!and!its!coM
chaperones! (7).! HSF1! is! then! sumoylated! and! recruits! the! transcriptional! elongation! factor! pM
TEFb! and! RNA! polymerase! II,! thus! initiating! increased! expression! of! heat! shock! proteins.! The!









turnMhelix! DNA! binding! domain! and! three! leucine! zippers! that! mediate! trimerization! of! the!




20! kDa! middle! regulatory! domain! that! is! proposed! to! interact! with! Hsp90.! This! region! is!
extensively!modified! by! phosphorylation,! sumoylation,! and! acetylation! (4,! 7,! 8,! 10).! A! fourth!
leucine!zipper! (LZ4)!appears! to!repress! trimerization!by! interacting!with!the! first! three! leucine!
zippers! in! the! monomeric! conformation! (2,! 11).! Finally,! the! extreme! CMterminus! contains! an!






HSF1! activation! deploys! higher! levels! of! expression! of! chaperones,! including! sHsps.! For! this!
reason,! activation! of! HSF1! may! be! a! promising! therapeutic! strategy! in! diseases! of! protein!
misfolding!(2).!A!small!molecule!modulator!could!activate!HSF1!in!a!number!of!different!ways.!A!
ligand! could! directly! bind! HSF1! and! inhibit! its! interaction! with! chaperones! in! the! cytoplasm,!
favoring! diffusion! into! the! nucleus;! it! could! induce! or! stabilize! trimerization,! which!would! be!
expected! to! favor!DNA!binding;! or! it! could!otherwise! stabilize! the!HSF1Mnucleic! acid! complex.!
Similar! to! sHsps,!HSF1! activation! confers! a! selective! advantage! to! cancer! cells,!which! have! to!
survive!under!stress!conditions.!Thus,!a!pharmacological!means!to!activate!or!upregulate!HSF1!
would! be! expected! to! be! protective! in! protein–misfolding! associated! neurotoxicities,! but!
inhibition!of!HSF1!would!be!preferable!in!cancers!(1,!2).!There!is!a!lack!of!detailed!mechanistic!
understanding! of! the! mechanism! of! action! of! HSF1! and! especially! its! proteinMprotein!
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interactions.! Chemical! probes! that! tune! its! structure! and!DNAMbinding! capacity! in! predictable!
ways!in%vitro!would!be!invaluable!tools!for!HSF1!biology!in!cell!culture!and!in%vivo%(1).!!
!
However,! HSF1! does! not! have! known! small! molecule! binding! sites,! and! its! proteinMprotein!
interactions!are!poorly! characterized.! It! lacks! structural! characterization!with! the!exception!of!
its!conserved!DNA!binding!domain.!DNA!binding!domains!are!notoriously!difficult!targets!due!to!
the! electrostatic! character! of! nucleic! acid! binding! interactions! (12).! Moreover,! HSF1’s! DNA!
binding!activity!is!the!only!robust!in%vitro!metric!associated!with!its!structure!and!function;!like!
sHsps,!it!lacks!intrinsic!enzymatic!activity.!Its!homoMoligomerization!is!linked!to!regulation!of!its!
transcriptional! activities,! further! complicating! ligand! discovery! efforts.! Chemical! validation! of!
HSF1! as! a! potential! therapeutic! target! necessitates! asking! the! same! types! of! questions! that!
apply! to!sHsps:!Are! there! ligand!binding!pockets?!Can!molecules!be! found!which!modulate! its!
structure!and!function?!What!is!the!‘active’!conformation!of!the!protein?!What!does!it!mean!to!
activate!or!inhibit!HSF1?!How!can!one!design!a!screen!for!allosteric!small!molecule!modulators?!
Because! HSF1! represents! an! interesting! target! and! because! its! study! could! benefit! from!





introduced! in! Chapter! 1! and! applied! to! sHsps! in! Chapters! 3! and! 4.! DSF! is! well! suited! to! the!
identification!of!ligands!that!interact!with!a!target!protein!in!the!absence!of!knowledge!of!ligand!
binding! sites,! and! is! not! impeded! by! conformational! heterogeneity.! The! technique! is! highM
throughput,! uses! small! amounts! of! protein,! and! is! amenable! to! discovery! in! the! absence! of!
target!enzymatic!activity.!Ligands!contribute!free!energy!of!binding!to!native!or!nonnative!forms!




giving! consistent! sigmoidal! melting! curves! with! midpoints! ranging! from! 33.0°C! and! 47.0°C,!
depending!on!the!composition!of!the!buffer!used!in!the!assay.!We!first!wanted!to!examine!the!
effect! of! DNA! binding! on! the! melting! temperature! of! HSF1.! An! idealized! 22Mbase! doubleM
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!
stranded!heat! shock!element!oligonucleotide!was!used!as!a!model!of! a!heat! shock!promoter.!
The! sequence! of! this! oligonucleotide! is! 5’MCCTGGAATATTCCCGAACTGGCM3’,! where! the! HSF1!
recognition! sequences!are! indicated! in!bold!and!underlined.! This! sequence! can!accommodate!
the!binding!of!a! trimer!of!HSF1.!A!22Mbase!doubleMstranded!oligonucleotide!with!each!binding!
site! mutated! to! nonbinding! sequences,! 5’MCCTGGCGTAGTCCCCGCCTGGCM3’,! was! used! as! a!
negative!control.!The!heat!shock!elementMcontaining!oligonucleotide!(HSE)!was!found!to!bind!to!
purified! monomeric! HSF1! with! an! apparent! affinity! of! 122.9! ±! 25.1! nM! by! a! fluorescence!















platform! for! the! identification! of! ligands! for! HSF1,! each! component! of! the! assay! was!
systematically! optimized.! First,! the! effect! of! DMSO!was! determined! by! systematically! varying!
DMSO! concentration! from! 0! to! 5%.! The! environmentally! sensitive! chromophore! used! in! this!
















from!0.15%!(sample!1)! to!5.15%!(sample!7).! In! the!bar!graph,!each!value! is! the!average!of! four! replicates,!and!the!




Next,! the! concentration! of! sodium! chloride! in! the! assay! buffer! was! systematically! varied,! as!
DNAMprotein! interactions! are! known! to! be! sensitive! to! salt! concentration.! Indeed,! lower!
concentrations!of! salt! (75!mM!as! shown! in!Figure!A.5)!appeared! to!potentiate! the! increase! in!
thermal!stability!associated!with!HSE!DNA!binding.!This!may!be!due!to!sodium!ions!competing!
for! ionic! interactions!with! the!DNA!backbone.!We! chose! to! include! 75!mM!NaCl! in! the! assay!
buffer.!Inclusion!of!lower!salt!also!led!to!a!‘flattening’!in!the!HSEMbound!HSF1!melting!curve!(see!





Tm$ SEM$ N$ Tm$ SEM$ N$ ΔTm$(°C)$
75$mM$NaCl$ 52.3$ 0.3$ 3$ 38.9$ 0.2$ 4$ 13.4$
100$mM$NaCl$ 42.3$ 0.1$ 4$ 39.0$ 0.1$ 4$ 3.3$
125$mM$NaCl$ 42.3$ 0.05$ 4$ 39.4$ 0.2$ 4$ 2.9$









As! discussed! in! section! A.2.1,! HSF1! contains! several! cysteines! that! form! intramolecular! and!
perhaps! also! intermolecular! disulfide! bonds.! Consequently,! we! next! examined! the! effect! of!
reducing! agent! on! the! behavior! of! HSF1! and! HSEMbound! HSF1! in! the! differential! scanning!
fluorimetry! assay.! Interestingly,! inclusion! of! the! reducing! agent! dithiothreitol! (DTT)! had! a!
profound!effect!on!the!observed!ΔTm!of!HSE!DNA!binding!(Figure!A.6).!Moreover,!the!effect!of!
DTT!was!dependent!on! the!amount!of! salt! that!was! included.!At!100!mM!NaCl,! inclusion!of!5!
mM! DTT! decreased! the! unbound! HSF1! Tm! and! increased! the! bound! HSF1! Tm! such! that! the!
resulting! ΔTm! of! HSE! binding! was! 15.6°C! (as! compared! to! 3.3°C! in! the! absence! of! reducing!




that! the! recombinant! purified! HSF1! is! trapped! in! a! disulfideMbound! conformation! that! is! not!
competent! to! fully! bind! HSE! DNA.! Inclusion! of! reducing! agent! frees! those! disulfide! bonds,!
leading!to!an!apparently!less!stable!HSF1!conformation!that!melts!at!a!lower!temperature!in!the!
absence! of! DNA! binding.! However,! in! the! presence! of! HSE! DNA,! this! conformation! is! more!












HCl)! would! have! the! same! effect! as! DTT! in! this! platform.! Either! TCEPMHCl! or! the! equivalent!




TCEP! is! often! used! in! highMthroughput! screening! because! it! is! more! inert! to! reaction! with!




(Figure! A.8).! Higher! concentrations! of! TCEP! (2! mM! or! 2.5! mM)! decreased! the! upper,! postM












DTT$ NaCl$ Tm$ SEM$ N$ Tm$ SEM$ N$ ΔTm$(°C)$
none$ 100$mM$ 42.3$ 0.1$ 4$ 39.0$ 0.1$ 4$ 3.3$
5$mM$ 100$mM$ 48.5$ 0.4$ 4$ 32.9$ 0.02$ 4$ 15.6$
none$ 150$mM$ 42.1$ 0.1$ 4$ 39.6$ 0.2$ 4$ 2.5$




































the! derivative! fit.! Red! bars! represent! samples! containing! a! 1:1! ratio! of! HSE! DNA! to! HSF1! (calculated! relative! to!
trimeric!HSF1),!while!the!blue!bars!represent!samples!containing!a!1:1!ratio!of!HSE!mutant!DNA!to!HSF1.!
!
Because! differential! scanning! fluorimetry! (and! other! HTS! techniques)! are! prone! to! the!

























The! final! conditions! for! the! pilot! screen! included! 0.1!mg/mL! (~1.7! μM)!wild! type!monomeric!
HSF1!and!50!μM!1,8MANS!in!25!mM!HEPES!pH!7.5!containing!75!mM!NaCl,!1!mM!MgCl2,!1!mM!
TCEP,!0.005%!TweenM20,!and!0.5%!DMSO.!Compounds!were!tested!at!10!μM!and!singleplexed.!
Each! well! contained! a! final! well! volume! of! 10! μL! overlaid! with! 2! μL! silicon! oil.! Plates! were!
centrifuged! for! 2!min! at! 1000! rpm!before! running,! and! the! signal!was!measured! to!be! stable!
over!10!hours!when!stored!at!4°C!in!the!dark!(to!ensure!that!a!day’s!plates!could!all!be!made!up!
in! the! morning! and! run! over! the! course! of! the! day,! without! compromising! data! quality).!
Negative!controls!contained!0.5%!DMSO!only,!and!positive!controls!contained!0.5%!DMSO!+!560!
nM!HSE!DNA.!Plates!were!run!on!the!Johnson!&!Johnson!ThermoFluor!instrument!from!25M70°C!



















A! total! of! 3154! compounds! were! screened,! which! required! thirteen! plates! and! two! days! to!
complete.!Characteristics!of! the! three! libraries! that!were!screened!are!described! in!Table!A.1.!
The!hit!rates!for!the!primary!screen!are!described!in!the!flowchart!in!Figure!A.12,!below.!Using!a!
three!standard!deviation!cutoff!(calculated!for!the!negative!controls!across!the!entire!campaign)!
a! total! of! 85! hits! were! identified! from! the! automated! analysis! protocol! described! briefly! in!
Chapter! 3! (3.8.3.).! This! corresponds! to! a! hit! rate! of! 2.6%.! Of! these,! 68! hits! caused! negative!
deflection! in! Tm! while! 17! hits! increased! Tm.! The! melting! curves! for! each! hit! were! visually!
inspected! and! excluded! if! the! curve! shape! was! poor,! noisy,! or! suggested! a! fluorescent!
compound,!aggregation!of!the!protein,!or!a!quenching!interaction!with!the!solvatochromic!dye.!
This!excluded!9!wells,!leaving!61!negative!hits!and!15!positive!hits.!A!wide!range!of!Tms!was!seen!
for! the! 61! negative! hits! (spanning! M1.3°C! to! M7.8°C! relative! to! the! average! of! the! negative!
controls),! and! relatively! small! positive! changes! were! observed! from! the! 15! positive! hits!
(spanning! +1.3°C! to! +2.7°C).! From! these,! 16! hits! were! obtained! for! reconfirmation,! equally!








1.3°C! to! M7.8°C)! than! the! relatively! small! positive! changes! observed! from! the! 15! positive! hits! (spanning! +1.3°C! to!
+2.7°C).!
(
The!results!of! the!reconfirmation!effort!are!shown! in!Figure!A.13! in!a!bar!graph!and!summary!
table.! The! chemical! structures! for! the! sixteen! reconfirmation! compounds!are! shown! in! Figure!
A.14.!Compounds!were!again! screened!at!10!μM!under! the! same!conditions!as! in! the! screen.!
While! the! controls!wells! performed! as! expected,! only! epigallocatechin! gallate! (EGCG,!15)! and!
cedryl!acetate!(16)!appeared!to!reconfirm!in!this!experiment.!The!original!change!in!Tm!for!EGCG!
was!M2.2°C,!and!in!the!reconfirmation!experiment!it!was!only!about!M1°C.!Upon!closer!inspection,!
it! appeared! that! EGCG! competed! with! or! quenched! 1,8MANS! fluorescence! and! the! resulting!
altered!curve!shape!accounted!for!the!decrease!in!Tm.!Additionally,!polyphenols!are!known!to!be!
very! promiscuous! binders! and! so! EGCG! was! not! considered! as! a! viable! scaffold! for! further!
development.! The! changes! observed! in! the! reconfirmation! experiments! with! cedryl! acetate!
were!not!significant!(Figure!A.15).!
((((( (
Figure!A.13.!Result!of! singleMconcentration! reconfirmation! (at!10!μM)! from!16! repurchased!or!borrowed!hits.! Each!















preparation!of!protein!was!used! for! the! reconfirmation!versus! the!primary!screen,!which!may!






The! pilot! screen! described! in! the! previous! section! used! monomeric,! wild! type! HSF1! in! the!
presence!of!reducing!agent!and!in!the!absence!of!any!of!HSF1’s!binding!partners,!including!HSE!
DNA! or! molecular! chaperones.! The! differential! scanning! fluorimetry! platform! can! easily! be!















of! distinct! physicochemical! phenomena.! These! include! straightforward! increases! in! thermal!
stability!due!to!the!energy!of!ligand!binding!to!a!given!conformation!or!conformations,!complex!
formation! with! nucleic! acid,! and! conformational! changes! of! HSF1! that! reflect! differential!










Similarly,! characterization!of! constructs!with!different! conformations!or! quaternary! structures!
may!help! to! identify! the!biophysical! signatures!of! different! conformations.! This! in! turn!would!
enable! a! DSF! screen! for! identifying! ligands! that! favor! specific! protein! conformations! or!
oligomeric! states! of! HSF1.! In! addition! to! the! monomeric! form,! the! recombinant! wild! type!
protein! elutes! as! an! oligomer! (possibly! a! trimer)! when! purified! by! sizeMexclusion!
chromatography! by!members! of! the! Thiele! laboratory.! Additionally,! the! Thiele! laboratory! has!
developed! constructs! of! HSF1! that! lack! critical! oligomerization! domains! or! are! constitutively!
oligomerized.!We!began!to!study!these!proteins!by!differential!scanning!fluorimetry!in!order!to!








apparent! affinities! for! the! HSE! oligonucleotide! of! 122.9! ±! 25.1! nM! and! 12.1! ±! 2.1! nM!
respectively.!!
!
The! LZ1M3! construct! lacks! the! leucine! zipper! trimerization! domain,! and! so! it! is! constitutively!
monomerized!(Figure!A.17).!As!expected,!the!constitutive!monomer!binds!rather!weakly!to!the!
HSE!oligonucleotide!with!an!apparent!affinity!of!609.3!±!160.5!nM!as!measured!by!FP.!By!DSF,!
this! construct! does! not! appear! to! bind! to! HSE! DNA! at! a! stoichiometric! concentration! (Figure!
A.18).!The!LZ4!construct!has!L391M,!L395P,!and!L398P!point!mutations!in!the!LZ4!domain!that!
result!in!a!constitutively!trimerized!HSF1!(11)!(Figure!A.17).!Its!affinity!for!HSE!oligonucleotide!is!




Lastly,! the! Agard! laboratory! has! cloned! a! slightly! shortened! construct! lacking! the! NM! and! CM
terminal! intrinsically! disordered! regions,! which! might! be! more! amenable! to! structural!





























to!obtain!a!homogenous!dispersion!of!particles! for! class!averages.!Despite! separation!by! sizeM
exclusion!chromatography!immediately!prior!to!the!preparation!of!grids,!HSF1!was!observed!as!
a!heterogeneous!mixture!of!conformations!(Figure!A.19).!!
HSE mutant HSE HSE mutant HSE 
Tm (°C)  SEM Tm (°C)  SEM ΔTm (°C) Tm (°C)  SEM Tm (°C)  SEM ΔTm (°C) 
wt monomer 45.99 0.07 47.61 0.19 1.62 44.02 0.21 62.74 0.33 18.72 
wt trimer 36.32 0.91 42.52 1.67 6.20 41.10 0.94 44.86 0.66 3.76 
LZ4m trimer 35.97 0.14 50.09 2.54 14.13 42.63 0.46 59.08 0.73 16.45 



























































































































































uncomplicated! by! the! presence! of! other! quaternary! structures,! we! considered! a! DNAM
templating! strategy.! A! double! stranded! DNA! oligonucleotide! was! designed! containing! five!
idealized!HSEs!in!sequence!(Figure!A.20).!Using!DSF!and!an!electrophoretic!mobility!shift!assay,!
HSF1!was!confirmed!to!bind!to!the!oligonucleotide.!However,!the!stoichiometry!of!the!binding!
interaction! is! not! clear! from! these!measurements,! and! an! optimized! electrophoretic!mobility!







However,! since!HSF1! is! known! to!bind! to!DNA!as! trimers,! this! templating! strategy!may!prove!
useful! to! facilitate! its! structural! characterization.! Electron!microscopy! of! HSF1! is! expected! to!
provide! a! useful! tool! for! the! study! of! small! molecules! that! alter! oligomerization! state.!




The! longMterm! goals! of! this! work! are! to! understand! how! we! can! activate! HSF1! using! small!
molecules!with!the!end!goal!of!developing!therapeutics!for!neurodegenerative!diseases.!Where!
are! the! small! molecule! binding! sites! within! HSF1?! Is! it! possible! to! inhibit! the! interactions! of!
Hsp70! and! Hsp90! with! HSF1! by! binding! to! HSF1?! Can! one! develop! an! HSF1! ligand! that!
potentiates!DNA!binding,!possibly!through!stabilization!of!the!trimeric!form?!Future!work!should!
extend! the! DSF! screening! effort! described! herein! towards! the! goal! of! identifying! such!
modulators,! and! complete! the! reconfirmation! effort! of! the! other! scaffolds! identified! in! the!
initial!pilot!screen.!A!parallel!comparison!of!a!second!small!pilot!screen!carried!out!against!the!
complex!of!HSF1!with!HSE!DNA!(Figure!A.16)!should!be!informative!as!to!the!best!path!forward.!
If! neither! format!of! the!DSF! screen! is! fruitful! in! producing! robust,! reproducible!hits,! then! the!











Plates! were! centrifuged! for! 2! min! at! 1000! rpm! before! running! on! a! Johnson! &! Johnson!
ThermoFluor!instrument!from!25M70°C!in!continuous!ramp!mode,!at!a!rate!of!30!sec!per!degree.!










stocks! were! added! in! 200! nL! drops! by! a! pin! tool! in! the! Center! for! Chemical! Genomics! and!
followed! by! a! protein,! 1,8MANS,! and! buffer! solution.! Negative! controls! contained! 0.5%!DMSO!




The! electrophoretic! mobility! shift! assay! protocol! was! adapted! from! (14).! Briefly,! a! vertical,!











injected! and! separated! at! 0.5! mL/min,! eluting! as! a! single! peak! centered! at! 14! mL! elution!
volume.! A! fraction! in! the! center! of! this! peak! was! collected,! diluted! 1:10! into! freshly! filtered!
buffer,! and! applied! to! glowMdischarged! Formvar/carbon! 300Mmesh! copper! grids! (Electron!
Microscopy!Sciences).!The!total!time!from!elution!from!the!chromatography!column!to!gridding!
samples! was! less! than! ten! minutes.! Grids! were! washed! with! water,! stained! with! 2%! uranyl!






Alex! Jaeger! in! Dennis! Thiele’s! laboratory! at! Duke! University! expressed! and! purified! the! wild!
type,!ΔLZ1M3,!and!LZ4m!HSF1!proteins,!designed!the!HSE!and!HSE!mutant!DNA!oligonucleotides,!
and! measured! the! binding! constants! using! fluorescence! polarization.! A! construct! containing!
residues! 16M417,! lacking! the! disordered! CMterminal! activation! domain,!was! cloned,! expressed,!
and!purified!by!Joe!Tao!of!the!Agard!laboratory.!Thomas!McQuade!in!the!University!of!Michigan!
Center!for!Chemical!Genomics!(CCG)!kindly!set!up!the!plates!for!the!pilot!screen!and!provided!
useful!help!and!feedback!in!the!design!of!the!screen.!!
!
A.11.(References(
1.! Neef!DW,!Turski!ML,!Thiele!DJ.!Modulation!of!heat!shock!transcription!factor!1!as!a!
therapeutic!target!for!small!molecule!intervention!in!neurodegenerative!disease.!PLoS!biology.!
2010;8(1):e1000291.!
2.! Neef!DW,!Jaeger!AM,!Thiele!DJ.!Heat!shock!transcription!factor!1!as!a!therapeutic!target!
in!neurodegenerative!diseases.!Nature!reviews!Drug!discovery.!2011;10(12):930M44.!
3.! Bharadwaj!S,!Ali!A,!Ovsenek!N.!Multiple!components!of!the!HSP90!chaperone!complex!
function!in!regulation!of!heat!shock!factor!1!In!vivo.!Molecular!and!cellular!biology.!
1999;19(12):8033M41.!
4.! Akerfelt!M,!Morimoto!RI,!Sistonen!L.!Heat!shock!factors:!integrators!of!cell!stress,!
development!and!lifespan.!Nature!reviews!Molecular!cell!biology.!2010;11(8):545M55.!
5.! Sorger!PK,!Nelson!HC.!Trimerization!of!a!yeast!transcriptional!activator!via!a!coiledMcoil!
motif.!Cell.!1989;59(5):807M13.!
6.! Ahn!SG,!Thiele!DJ.!Redox!regulation!of!mammalian!heat!shock!factor!1!is!essential!for!
Hsp!gene!activation!and!protection!from!stress.!Genes!&!development.!2003;17(4):516M28.!
7.! Abravaya!K,!Myers!MP,!Murphy!SP,!Morimoto!RI.!The!human!heat!shock!protein!hsp70!
interacts!with!HSF,!the!transcription!factor!that!regulates!heat!shock!gene!expression.!Genes!&!
development.!1992;6(7):1153M64.!
8.! Guo!Y,!Guettouche!T,!Fenna!M,!Boellmann!F,!Pratt!WB,!Toft!DO,!et!al.!Evidence!for!a!
mechanism!of!repression!of!heat!shock!factor!1!transcriptional!activity!by!a!multichaperone!
complex.!The!Journal!of!biological!chemistry.!2001;276(49):45791M9.!
9.! Shi!Y,!Mosser!DD,!Morimoto!RI.!Molecular!chaperones!as!HSF1Mspecific!transcriptional!
repressors.!Genes!&!development.!1998;12(5):654M66.!
10.! Ahn!SG,!Liu!PC,!Klyachko!K,!Morimoto!RI,!Thiele!DJ.!The!loop!domain!of!heat!shock!
transcription!factor!1!dictates!DNAMbinding!specificity!and!responses!to!heat!stress.!Genes!&!
development.!2001;15(16):2134M45.!
11.! Neef!DW,!Jaeger!AM,!Thiele!DJ.!Genetic!selection!for!constitutively!trimerized!human!
HSF1!mutants!identifies!a!role!for!coiledMcoil!motifs!in!DNA!binding.!G3.!2013;3(8):1315M24.!
12.! Bauer!RA,!Wurst!JM,!Tan!DS.!Expanding!the!range!of!'druggable'!targets!with!natural!
productMbased!libraries:!an!academic!perspective.!Current!opinion!in!chemical!biology.!
2010;14(3):308M14.!
13.! Rauch!JN,!Nie!J,!Buchholz!TJ,!Gestwicki!JE,!Kennedy!RT.!Development!of!a!capillary!
electrophoresis!platform!for!identifying!inhibitors!of!proteinMprotein!interactions.!Analytical!
chemistry.!2013;85(20):9824M31.!
!!148!
!
14.! Zuo!J,!Baler!R,!Dahl!G,!Voellmy!R.!Activation!of!the!DNAMbinding!ability!of!human!heat!
shock!transcription!factor!1!may!involve!the!transition!from!an!intramolecular!to!an!
intermolecular!tripleMstranded!coiledMcoil!structure.!Molecular!and!cellular!biology.!
1994;14(11):7557M68.!
!
